[
  {
    "title": "Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program in Presentation at ObesityWeek\u00ae 2025 - PR Newswire",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQYmxrczFaWUNfUFBxYUQ0SGYzUDI3a19FQ2VfcjNwQ2gwcmpSVE8yWjNKc2J5OHNuQjRIQy16Y0lja0RDaHhpS1RFbEhnRXpNWXdyd05qbEtCX2hUYWU2ZzZYUlJsQkRTZU54NTNvVjF3YU1KOThXOXpvZHZZNHBlUHZsOGZOMlh1eFpnYnVNREpSRVBTYmtTdUI5eW92dGhYU2J6WUZ2VFZwRXozY2lVQlVCLVVtU3dGWnMyMEFKMVY2SWFQa2hFRU5LU2FEVi00VC1rV25wM044QkZRc1R0TTZDUl9TdXdxam4yVmtRQzdDQkxISXA0?oc=5\" target=\"_blank\">Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program in Presentation at ObesityWeek\u00ae 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
    "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxQYmxrczFaWUNfUFBxYUQ0SGYzUDI3a19FQ2VfcjNwQ2gwcmpSVE8yWjNKc2J5OHNuQjRIQy16Y0lja0RDaHhpS1RFbEhnRXpNWXdyd05qbEtCX2hUYWU2ZzZYUlJsQkRTZU54NTNvVjF3YU1KOThXOXpvZHZZNHBlUHZsOGZOMlh1eFpnYnVNREpSRVBTYmtTdUI5eW92dGhYU2J6WUZ2VFZwRXozY2lVQlVCLVVtU3dGWnMyMEFKMVY2SWFQa2hFRU5LU2FEVi00VC1rV25wM044QkZRc1R0TTZDUl9TdXdxam4yVmtRQzdDQkxISXA0?oc=5",
    "source": "PR Newswire",
    "publish_date": "Thu, 06 Nov 2025 12:05:00 GMT"
  },
  {
    "title": "Is There a Future for Viking Therapeutics? - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTE5NbHNhRlVqWXFwelVGdnBJMmM3ZW5ncGVTQ1B3SXhYSUtHTDlmVFVyVVREVFU2SE9HUGROdGtzRy1PbzFJQnBEc3JPcy1vTDVjTmRtNDd0VDVUZWtrVk5KM05oVHE3UC1hMy1ENkpIcUFQc051ckZuOFlsY2U?oc=5\" target=\"_blank\">Is There a Future for Viking Therapeutics?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5NbHNhRlVqWXFwelVGdnBJMmM3ZW5ncGVTQ1B3SXhYSUtHTDlmVFVyVVREVFU2SE9HUGROdGtzRy1PbzFJQnBEc3JPcy1vTDVjTmRtNDd0VDVUZWtrVk5KM05oVHE3UC1hMy1ENkpIcUFQc051ckZuOFlsY2U?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Sun, 09 Nov 2025 11:55:00 GMT"
  },
  {
    "title": "Is There a Future for Viking Therapeutics? - The Motley Fool",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxON21mOUgxd29WQk95dDRLSjhQbmJvMGE3RU5nUFNSSWd3enhoZGtmenVBQVh1SVNyVzBVd2lXNmNKMHRYTEY2R3pjWUFCbU5LMm9McTk0SEo3UF9hbkxoanFuZWNpREpqWm5veHVXSnhZYWRwaW1IYXlTT09zQnhKQ2NPQjVLcXVVbElrbg?oc=5\" target=\"_blank\">Is There a Future for Viking Therapeutics?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
    "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxON21mOUgxd29WQk95dDRLSjhQbmJvMGE3RU5nUFNSSWd3enhoZGtmenVBQVh1SVNyVzBVd2lXNmNKMHRYTEY2R3pjWUFCbU5LMm9McTk0SEo3UF9hbkxoanFuZWNpREpqWm5veHVXSnhZYWRwaW1IYXlTT09zQnhKQ2NPQjVLcXVVbElrbg?oc=5",
    "source": "The Motley Fool",
    "publish_date": "Sun, 09 Nov 2025 11:55:00 GMT"
  },
  {
    "title": "Viking Therapeutics\u2019 VK2735: A Promising Step Forward in Metabolic Disease Treatment Justifying a Buy Rating - TipRanks",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNNjhQZ1E4MXUyQ3gyWE9tRDhhZGliUWxDYzl2VjFsdGczbE9vUVkxUlQwTGlLREprbHg0aTZWUmFUc3BkdlNpSy00YmZQa1VDWHFYMHdCMnR3aTZObnJCSl83N3ZneC14Ym9vRG5ySmMtWWUzMVNfVUFxSUNaWURHMmRkZnhGZ0FsZnFrd2RQZmhaNEtkeU15b1RpVjJlbEJNSXZoYUFjVkxjcjh6SVhCYXpHZUtKT1hSZUk2X2RWSDdKZUMzX2tZTkpuVjFkWDRNcU9DcXBHQ0Z1aHVidE81N29kUkNkalk?oc=5\" target=\"_blank\">Viking Therapeutics\u2019 VK2735: A Promising Step Forward in Metabolic Disease Treatment Justifying a Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
    "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNNjhQZ1E4MXUyQ3gyWE9tRDhhZGliUWxDYzl2VjFsdGczbE9vUVkxUlQwTGlLREprbHg0aTZWUmFUc3BkdlNpSy00YmZQa1VDWHFYMHdCMnR3aTZObnJCSl83N3ZneC14Ym9vRG5ySmMtWWUzMVNfVUFxSUNaWURHMmRkZnhGZ0FsZnFrd2RQZmhaNEtkeU15b1RpVjJlbEJNSXZoYUFjVkxjcjh6SVhCYXpHZUtKT1hSZUk2X2RWSDdKZUMzX2tZTkpuVjFkWDRNcU9DcXBHQ0Z1aHVidE81N29kUkNkalk?oc=5",
    "source": "TipRanks",
    "publish_date": "Fri, 07 Nov 2025 18:17:37 GMT"
  },
  {
    "title": "Viking releases new data on VK2735 in prediabetes, metabolic syndrome - Seeking Alpha",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxOcnlWaDRVVlJxR3dHcG9hckVhTkhmWk1LdFV1ajdreVctZ0IzckdPY2RaSzJrTU1Iby1pRF9BWXVSdXNmYjdnN3BzcUpOTUJVQ3hPMlVvVnIyTVpfR3lxZEY2akpvNWNMV2IzZzBteGprS0RUbFJ5UDZVN2Z6OGl5T2F5OW0xYl9xVmdfZmgteFM2NFFuSTRPd0dTdWROQjRZR0E?oc=5\" target=\"_blank\">Viking releases new data on VK2735 in prediabetes, metabolic syndrome</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOcnlWaDRVVlJxR3dHcG9hckVhTkhmWk1LdFV1ajdreVctZ0IzckdPY2RaSzJrTU1Iby1pRF9BWXVSdXNmYjdnN3BzcUpOTUJVQ3hPMlVvVnIyTVpfR3lxZEY2akpvNWNMV2IzZzBteGprS0RUbFJ5UDZVN2Z6OGl5T2F5OW0xYl9xVmdfZmgteFM2NFFuSTRPd0dTdWROQjRZR0E?oc=5",
    "source": "Seeking Alpha",
    "publish_date": "Thu, 06 Nov 2025 16:59:56 GMT"
  },
  {
    "title": "Jim Cramer Recommends Eli Lilly Over Viking Therapeutics - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxQMzN6bmNmWE96UjVPTUczUmNrb0FZQ1lZNVhfZExDVURVUVlMbnh5SE9FSkRFcWtmNVR1UkhpdTFUSmVKSEl1b21xblhhb0cySjNaVGNqLURUZFhBTzBBV2RSakYzVTV3aUFwcWRMRE9kdEtDVGhzdFByamdzclZWUmI3QQ?oc=5\" target=\"_blank\">Jim Cramer Recommends Eli Lilly Over Viking Therapeutics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQMzN6bmNmWE96UjVPTUczUmNrb0FZQ1lZNVhfZExDVURVUVlMbnh5SE9FSkRFcWtmNVR1UkhpdTFUSmVKSEl1b21xblhhb0cySjNaVGNqLURUZFhBTzBBV2RSakYzVTV3aUFwcWRMRE9kdEtDVGhzdFByamdzclZWUmI3QQ?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Thu, 06 Nov 2025 19:19:58 GMT"
  },
  {
    "title": "Viking Therapeutics Could Be Pharma\u2019s Next Big Buyout Target - 24/7 Wall St.",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxNY3lzYUN0MEtYZzY5ckRjZTk4M0tIWnZKeW0zWEdpV05tbnVKVU5UVXZ5RGdQWUVGN2RVekV3akNSQ2FoR2tacmlmRTZjVjlobl85cDJkT2o2blBUdHZwR3Vpei15THFPQWZkMDlILWY3RXhsb3pQalJrVUphS3VaQnVCeDFyZWxva0ItUkJXbEJYdlZmWXkxdUdVcTJaVVdReVJqWUF3?oc=5\" target=\"_blank\">Viking Therapeutics Could Be Pharma\u2019s Next Big Buyout Target</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">24/7 Wall St.</font>",
    "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNY3lzYUN0MEtYZzY5ckRjZTk4M0tIWnZKeW0zWEdpV05tbnVKVU5UVXZ5RGdQWUVGN2RVekV3akNSQ2FoR2tacmlmRTZjVjlobl85cDJkT2o2blBUdHZwR3Vpei15THFPQWZkMDlILWY3RXhsb3pQalJrVUphS3VaQnVCeDFyZWxva0ItUkJXbEJYdlZmWXkxdUdVcTJaVVdReVJqWUF3?oc=5",
    "source": "24/7 Wall St.",
    "publish_date": "Mon, 03 Nov 2025 15:13:20 GMT"
  },
  {
    "title": "Is There a Future for Viking Therapeutics? - AOL.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiekFVX3lxTE52TUdMc0VWWWYxVGtyWEhadTVrVnlocG41ZV9LOXlrNU15eXFjNl9oVjJTY0JPaEZUQTVaQ3lOa2JsOTIzTkQwLWNpU3hpRmZEQ3dza3dqZlR6cTIyUjlOWmthRjFicVNQb1FNbkVhN1FfYnBtTlAwcEZR?oc=5\" target=\"_blank\">Is There a Future for Viking Therapeutics?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AOL.com</font>",
    "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE52TUdMc0VWWWYxVGtyWEhadTVrVnlocG41ZV9LOXlrNU15eXFjNl9oVjJTY0JPaEZUQTVaQ3lOa2JsOTIzTkQwLWNpU3hpRmZEQ3dza3dqZlR6cTIyUjlOWmthRjFicVNQb1FNbkVhN1FfYnBtTlAwcEZR?oc=5",
    "source": "AOL.com",
    "publish_date": "Sun, 09 Nov 2025 12:28:52 GMT"
  },
  {
    "title": "Using Bollinger Bands to evaluate Viking Therapeutics Inc. - July 2025 Outlook & Short-Term High Return Strategies - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxQcjBUZ1dueWhNRm01c3BNWURUcC1JbTkzMTJRZU9sQnA3Zk1kdThNdVZsa0lXRU8tM2dSUTJBZ0YxQU81RS1lZk93dDFTdHZGbTVLbmRqXzBqQnJaSkU1QlpRNm96NERTYlgtZ0wxdXlvYXh3RGF1cE9jcjUzLVRVMmtFZi1DN1l2a3JodnotWnRwTUFXYlNkUGt3?oc=5\" target=\"_blank\">Using Bollinger Bands to evaluate Viking Therapeutics Inc. - July 2025 Outlook & Short-Term High Return Strategies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQcjBUZ1dueWhNRm01c3BNWURUcC1JbTkzMTJRZU9sQnA3Zk1kdThNdVZsa0lXRU8tM2dSUTJBZ0YxQU81RS1lZk93dDFTdHZGbTVLbmRqXzBqQnJaSkU1QlpRNm96NERTYlgtZ0wxdXlvYXh3RGF1cE9jcjUzLVRVMmtFZi1DN1l2a3JodnotWnRwTUFXYlNkUGt3?oc=5",
    "source": "newser.com",
    "publish_date": "Sun, 09 Nov 2025 13:15:59 GMT"
  },
  {
    "title": "Here's Why Shares in Viking Therapeutics Shot Higher in October - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxOYjhPNmYyTFk2bTFwMGk0SzlTTzZtSW9UTVlscHNEYkNvV2paY1VfWTk5UGRHMm41V2hGbUhUTXZQU21zVG9oQmRCNG5OVTNQQ3ZGTGFnVG5PNGI2R3VkT0t6VjRuY0hRX3Q5R183aGlwUUNSUlB6bGhESzBFcmJXalo5dk1wSURhenc?oc=5\" target=\"_blank\">Here's Why Shares in Viking Therapeutics Shot Higher in October</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOYjhPNmYyTFk2bTFwMGk0SzlTTzZtSW9UTVlscHNEYkNvV2paY1VfWTk5UGRHMm41V2hGbUhUTXZQU21zVG9oQmRCNG5OVTNQQ3ZGTGFnVG5PNGI2R3VkT0t6VjRuY0hRX3Q5R183aGlwUUNSUlB6bGhESzBFcmJXalo5dk1wSURhenc?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Wed, 05 Nov 2025 10:15:00 GMT"
  },
  {
    "title": "Sell Novo Nordisk And Buy Viking Therapeutics (NASDAQ:VKTX) - Seeking Alpha",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxQenJKd3ktbThvTTNNbkxqNEQ0U3JLSG4wMEQ1NWlVZDZOWTh0UlpaQ211SE84RHlrQUVzNngzUEd2WHRROXJDSXgxbU9GRldRdkFaQ3Z6QXlDXzBVUmFHbDhoaDRLWEhOQk5YMmlsbVlrQjk0c1VudEdkNjFfRW0tNkZRMnZ6SjRGMXAzQXNkSQ?oc=5\" target=\"_blank\">Sell Novo Nordisk And Buy Viking Therapeutics (NASDAQ:VKTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQenJKd3ktbThvTTNNbkxqNEQ0U3JLSG4wMEQ1NWlVZDZOWTh0UlpaQ211SE84RHlrQUVzNngzUEd2WHRROXJDSXgxbU9GRldRdkFaQ3Z6QXlDXzBVUmFHbDhoaDRLWEhOQk5YMmlsbVlrQjk0c1VudEdkNjFfRW0tNkZRMnZ6SjRGMXAzQXNkSQ?oc=5",
    "source": "Seeking Alpha",
    "publish_date": "Mon, 03 Nov 2025 03:15:05 GMT"
  },
  {
    "title": "Viking Therapeutics (VKTX): Evaluating Valuation After New Obesity Drug Data Spurs Fresh Interest - simplywall.st",
    "content": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Viking Therapeutics (VKTX): Evaluating Valuation After New Obesity Drug Data Spurs Fresh Interest</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
    "url": "https://news.google.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?oc=5",
    "source": "simplywall.st",
    "publish_date": "Sat, 08 Nov 2025 05:03:49 GMT"
  },
  {
    "title": "Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies - Investor's Business Daily",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxOakpINnlGSEIxOEtlLXJaTGVqX3RRN1JqSWxyY3d0QThpdnk3dFN3b3VVN1RWS29SOEpfd0dIdHAyU1lZTUc2LUNSUjlyQ0ZJYkdLT1FOMzBKSkpQTWh6MEpkNEhsWk1fU0hQVzB2Q2RRMDZ6ZU92UWNwWmpJNjJ2WGtnMGo0bFdDZ1JyQzFBaExpX1g5QkIwY3BR?oc=5\" target=\"_blank\">Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
    "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOakpINnlGSEIxOEtlLXJaTGVqX3RRN1JqSWxyY3d0QThpdnk3dFN3b3VVN1RWS29SOEpfd0dIdHAyU1lZTUc2LUNSUjlyQ0ZJYkdLT1FOMzBKSkpQTWh6MEpkNEhsWk1fU0hQVzB2Q2RRMDZ6ZU92UWNwWmpJNjJ2WGtnMGo0bFdDZ1JyQzFBaExpX1g5QkIwY3BR?oc=5",
    "source": "Investor's Business Daily",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Can Viking Therapeutics Inc. stock reach $100 price target - Quarterly Trade Summary & AI Powered Market Entry Ideas - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxNNmw4RnJ5MC03WVVwZzF4dmwwbGYwT21faEZ1UVgwSFZRZ2J0LVVvOXRlOUhRM21UUEpVc0xhYU0xT21mMU5xQjE0ZW02a0w0MTBGZkwxMUhPb3B0QUxLVUtMb01TczRFa0dHdUZ4dDRVZy1sd29QSDI1eDFUMy1qRzhjUGk1N2pWeXU0ZFFTU1R3N2RicXhKaw?oc=5\" target=\"_blank\">Can Viking Therapeutics Inc. stock reach $100 price target - Quarterly Trade Summary & AI Powered Market Entry Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNNmw4RnJ5MC03WVVwZzF4dmwwbGYwT21faEZ1UVgwSFZRZ2J0LVVvOXRlOUhRM21UUEpVc0xhYU0xT21mMU5xQjE0ZW02a0w0MTBGZkwxMUhPb3B0QUxLVUtMb01TczRFa0dHdUZ4dDRVZy1sd29QSDI1eDFUMy1qRzhjUGk1N2pWeXU0ZFFTU1R3N2RicXhKaw?oc=5",
    "source": "newser.com",
    "publish_date": "Sun, 09 Nov 2025 12:08:34 GMT"
  },
  {
    "title": "Should You Buy Viking Therapeutics Before Nov. 5? - The Motley Fool",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxNSUJ6WWVucHRnZ1VhUFZZbHhfdVFUaXFORDBGM0lNR0QtZ0EtYXZQWFlONzl6eXBRTlhITmRUQWRZWjBPTFVaQU95S185RWxyakZCS05JcVdRQWJnNVVhZEotLXRQcm9vekdEX200cHRydVNPc0dYUHNQd3lCNEdkTG5fa1R1WnFrNjF6MWM1NU9nTTBl?oc=5\" target=\"_blank\">Should You Buy Viking Therapeutics Before Nov. 5?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
    "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNSUJ6WWVucHRnZ1VhUFZZbHhfdVFUaXFORDBGM0lNR0QtZ0EtYXZQWFlONzl6eXBRTlhITmRUQWRZWjBPTFVaQU95S185RWxyakZCS05JcVdRQWJnNVVhZEotLXRQcm9vekdEX200cHRydVNPc0dYUHNQd3lCNEdkTG5fa1R1WnFrNjF6MWM1NU9nTTBl?oc=5",
    "source": "The Motley Fool",
    "publish_date": "Sun, 02 Nov 2025 13:20:00 GMT"
  },
  {
    "title": "Viking Therapeutics: The Prime Target In The Obesity Gold Rush (NASDAQ:VKTX) - Seeking Alpha",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxQTkJXN0xaQ2ZkWC00bTNaWWVHOVJiSWxOTzFjTkZwSEhpWnBVQnRGb1BYSU1mUGF6YTk3MnRjVFk1dldYaFNNNnJKM3o2WGJ1OWdDbHVhRVNZbXNIUGtPdVNDb05HRV9fUDlVMkFSYmxUQW03UUFIcFdxOGp6SUthZl9EVklaazNwODBTdDVaemlGZ29PZVBwWVVRc196Wkk?oc=5\" target=\"_blank\">Viking Therapeutics: The Prime Target In The Obesity Gold Rush (NASDAQ:VKTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQTkJXN0xaQ2ZkWC00bTNaWWVHOVJiSWxOTzFjTkZwSEhpWnBVQnRGb1BYSU1mUGF6YTk3MnRjVFk1dldYaFNNNnJKM3o2WGJ1OWdDbHVhRVNZbXNIUGtPdVNDb05HRV9fUDlVMkFSYmxUQW03UUFIcFdxOGp6SUthZl9EVklaazNwODBTdDVaemlGZ29PZVBwWVVRc196Wkk?oc=5",
    "source": "Seeking Alpha",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcldDZldodmlldmpDNmZIR3B0aWF2LS1aOHBmUTBlMHVuN3BCMFdPYmFFRV9HTEVFbVRiWTJaQ2VuS2ZXZFdKaTdvb01teXlCd0Z0cG15TGp5dTRwT0ZJYzM1U1BhemszTnZjX1B0VU1XSWRNM21wUS1BRkJ3RTQ2RzJGemUxVDVVX2FvQmtrTldWX2Fwbk9xUEU2T3Qzb3llN24ySzEwYV9peUE0LVpycWJzb0ZsSWlWZ0tfNlZKbzJtTTFrMmVkN0NlRkMwQTlOaERIMXJJaUtJX09RV2g0SGE3MTY?oc=5\" target=\"_blank\">Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
    "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcldDZldodmlldmpDNmZIR3B0aWF2LS1aOHBmUTBlMHVuN3BCMFdPYmFFRV9HTEVFbVRiWTJaQ2VuS2ZXZFdKaTdvb01teXlCd0Z0cG15TGp5dTRwT0ZJYzM1U1BhemszTnZjX1B0VU1XSWRNM21wUS1BRkJ3RTQ2RzJGemUxVDVVX2FvQmtrTldWX2Fwbk9xUEU2T3Qzb3llN24ySzEwYV9peUE0LVpycWJzb0ZsSWlWZ0tfNlZKbzJtTTFrMmVkN0NlRkMwQTlOaERIMXJJaUtJX09RV2g0SGE3MTY?oc=5",
    "source": "PR Newswire",
    "publish_date": "Wed, 22 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek\u00ae 2025 - PR Newswire",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPY1c2VGVVSE42a082OWp5eVpUeVU0RTRKbmN3djdRa2tTTWU5bHFLODliRVc2akxVa014bW9rNWxHZkoxRmg4amxVTkM3OEg2N0pvYXVycU1oVjJLa2w5SE5URVc5TERTdG1NTkxXNVJYSkpTS2pKTGJ1WTFMUktpYVRlR2lHTXVSd25KMkxKN3pQMWxkSmlFdXhLa2tUVkx5WDdzQkFMS1BybW9CSDFielJaVlVRY2FmNVFKcU1RWlliZWloLU5ydlEyOHpmN3paSE5SWV82bUxQZG1jaGYzb1BqX2xMSWpxdEQxdm5VeDdSMlA3aUZJM0Vmdw?oc=5\" target=\"_blank\">Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek\u00ae 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
    "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxPY1c2VGVVSE42a082OWp5eVpUeVU0RTRKbmN3djdRa2tTTWU5bHFLODliRVc2akxVa014bW9rNWxHZkoxRmg4amxVTkM3OEg2N0pvYXVycU1oVjJLa2w5SE5URVc5TERTdG1NTkxXNVJYSkpTS2pKTGJ1WTFMUktpYVRlR2lHTXVSd25KMkxKN3pQMWxkSmlFdXhLa2tUVkx5WDdzQkFMS1BybW9CSDFielJaVlVRY2FmNVFKcU1RWlliZWloLU5ydlEyOHpmN3paSE5SWV82bUxQZG1jaGYzb1BqX2xMSWpxdEQxdm5VeDdSMlA3aUZJM0Vmdw?oc=5",
    "source": "PR Newswire",
    "publish_date": "Wed, 29 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Using Bollinger Bands to evaluate Viking Therapeutics Inc. - GDP Growth & Consistent Profit Trade Alerts - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxOeGRfVk1XYl9Yc1BLNVJBbUhUb3QtclNVSVMtN0xLLTl6aVppdW5mLVlMOFM1SGRldUpPV1Mwa2dONXNFYncwaVh5SnB4WGhudXR5Y2hzcHR4anE5VWs0QXpjbnpiQ0lYUjMwNTZxaFplQlgzYXgzXzFWaXlzT3didHp1elNiTUlhb0ZRQWFtZ19fWE9kQk1OUA?oc=5\" target=\"_blank\">Using Bollinger Bands to evaluate Viking Therapeutics Inc. - GDP Growth & Consistent Profit Trade Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOeGRfVk1XYl9Yc1BLNVJBbUhUb3QtclNVSVMtN0xLLTl6aVppdW5mLVlMOFM1SGRldUpPV1Mwa2dONXNFYncwaVh5SnB4WGhudXR5Y2hzcHR4anE5VWs0QXpjbnpiQ0lYUjMwNTZxaFplQlgzYXgzXzFWaXlzT3didHp1elNiTUlhb0ZRQWFtZ19fWE9kQk1OUA?oc=5",
    "source": "newser.com",
    "publish_date": "Sun, 09 Nov 2025 12:06:26 GMT"
  },
  {
    "title": "Viking Therapeutics Posts Wider-Than-Expected Loss in Q3, Sales Nil - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxPRU5SanJ6dG5iNUozc1dUWEdxZS02WG9sbmotOWhKVHNCakZ3VUMtNXZ4eVhCVVJFY1FnQmVJYXZCYnQ4VGNvd25zZEt4c2xubEtIMXhnSlNxNno4eFVaZEk3bXpaMGpET2hLR005UnBMS1k3cTVVRjBVUnl6QlpVcEtIOGhxRDZhQ1JZXzJ1cw?oc=5\" target=\"_blank\">Viking Therapeutics Posts Wider-Than-Expected Loss in Q3, Sales Nil</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPRU5SanJ6dG5iNUozc1dUWEdxZS02WG9sbmotOWhKVHNCakZ3VUMtNXZ4eVhCVVJFY1FnQmVJYXZCYnQ4VGNvd25zZEt4c2xubEtIMXhnSlNxNno4eFVaZEk3bXpaMGpET2hLR005UnBMS1k3cTVVRjBVUnl6QlpVcEtIOGhxRDZhQ1JZXzJ1cw?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Prediction: The Next Eli Lilly Might Already Be Trading Under $50 - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxOcEtWck9fQzVhSURYb1dNNW54Q05KRTBBWnRTZ3k0NGNGd1duU1pMQktvTHJ2cjE1eUpfZENBY3BtUXN2LTl1YlJVaWZBTHBiRS1YV1pnWjlTdk5LY3hXTkhGclVzb19SSGE1X2plcHpnOEhtYk1CYkN6SjVfVm14eEJJUQ?oc=5\" target=\"_blank\">Prediction: The Next Eli Lilly Might Already Be Trading Under $50</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOcEtWck9fQzVhSURYb1dNNW54Q05KRTBBWnRTZ3k0NGNGd1duU1pMQktvTHJ2cjE1eUpfZENBY3BtUXN2LTl1YlJVaWZBTHBiRS1YV1pnWjlTdk5LY3hXTkhGclVzb19SSGE1X2plcHpnOEhtYk1CYkN6SjVfVm14eEJJUQ?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Mon, 03 Nov 2025 09:45:00 GMT"
  },
  {
    "title": "Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxNR3JIZDdhSTlIdG1CUFFNZ19iemx2ODFxMnBPTVV5WE5MajMyWWhBYi1iZmNFOHJfMWMxelZzNkp5QnJ4amFQVEdXRVRtbGF1VUxzWExBUjFYQmEwN21PU3JGMG9scGk4ZUFUd0R2azYtZmF0bHpPeTQ4ZXhGNnNLY3p6TXExdw?oc=5\" target=\"_blank\">Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNR3JIZDdhSTlIdG1CUFFNZ19iemx2ODFxMnBPTVV5WE5MajMyWWhBYi1iZmNFOHJfMWMxelZzNkp5QnJ4amFQVEdXRVRtbGF1VUxzWExBUjFYQmEwN21PU3JGMG9scGk4ZUFUd0R2azYtZmF0bHpPeTQ4ZXhGNnNLY3p6TXExdw?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Mon, 27 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics to Participate at Upcoming Investor Conferences - Nasdaq",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxPM29tRVltOWl0cXNzT0l6eDZDTzBDWjEyMHotWVR4WVlZc0xGTlhyUTNNbm9UTlBBa3duY0xmVEdTc0FuV28tNmdRejJ2RWxTVEVlRWtuY2wzWmxSTHphTGtLRXJ6NzVDcTNIMkh1cndUdjFSTnFObm4yemtyMzJ6ZG1YalhsTGs1RjFWRTFYc0R2WlE3ZkR2dWdzVDlkMkdiVnlhWVJZRzJXQzdGY1E?oc=5\" target=\"_blank\">Viking Therapeutics to Participate at Upcoming Investor Conferences</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPM29tRVltOWl0cXNzT0l6eDZDTzBDWjEyMHotWVR4WVlZc0xGTlhyUTNNbm9UTlBBa3duY0xmVEdTc0FuV28tNmdRejJ2RWxTVEVlRWtuY2wzWmxSTHphTGtLRXJ6NzVDcTNIMkh1cndUdjFSTnFObm4yemtyMzJ6ZG1YalhsTGs1RjFWRTFYc0R2WlE3ZkR2dWdzVDlkMkdiVnlhWVJZRzJXQzdGY1E?oc=5",
    "source": "Nasdaq",
    "publish_date": "Tue, 04 Nov 2025 21:05:00 GMT"
  },
  {
    "title": "Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity - PR Newswire",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPYnk3M05nM2I4cE1uMkppOUloY1NDRWdQRVAzQnVmT1V0eExEVmdpSjVZSmIwOHFhckFmaU5qTmw0ME5QYTJqY0Y2VGdJeU54Q2lqbkRfbW16TGNDZ3ZIWmZrbzk3MlRXd0NRdVNSbDNsQ1dNSFdOQmw3Q1pIVVA0Njd3djItb2hnVHdMeEhJMEpJWTFlblY4c3lQemF1U0ZpUFRSMVdVMzY2N20tRGFucno4cDFSX2hIV3pPQTR3SmF4bDluNEpWaFFEMXZoRDI4dWU3c2pob0t6TjgwYllwYmJpXzBPanhWMUVsQ0xWRlFUNWJwbktoeA?oc=5\" target=\"_blank\">Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
    "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPYnk3M05nM2I4cE1uMkppOUloY1NDRWdQRVAzQnVmT1V0eExEVmdpSjVZSmIwOHFhckFmaU5qTmw0ME5QYTJqY0Y2VGdJeU54Q2lqbkRfbW16TGNDZ3ZIWmZrbzk3MlRXd0NRdVNSbDNsQ1dNSFdOQmw3Q1pIVVA0Njd3djItb2hnVHdMeEhJMEpJWTFlblY4c3lQemF1U0ZpUFRSMVdVMzY2N20tRGFucno4cDFSX2hIV3pPQTR3SmF4bDluNEpWaFFEMXZoRDI4dWU3c2pob0t6TjgwYllwYmJpXzBPanhWMUVsQ0xWRlFUNWJwbktoeA?oc=5",
    "source": "PR Newswire",
    "publish_date": "Tue, 21 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics Inc (VKTX) Q3 2025 Earnings Call Highlights: Strategic Advancements Amid ... - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxQN2FoOFNFYWFSbENxVjZVUjFFOHdCUXQyUjAzaDFtZGpOZWNUNkdRZnVzM2JwX241S3l6emhZcDZ4ZlZ4aDE4d25NUHJvSFdJQzVlQjFrU1RhM2F3dG16U0RWMUtmVVJ5aDFRd2daTzNmMWtqZHQycnhDZ1RNWHd1UHRiaw?oc=5\" target=\"_blank\">Viking Therapeutics Inc (VKTX) Q3 2025 Earnings Call Highlights: Strategic Advancements Amid ...</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQN2FoOFNFYWFSbENxVjZVUjFFOHdCUXQyUjAzaDFtZGpOZWNUNkdRZnVzM2JwX241S3l6emhZcDZ4ZlZ4aDE4d25NUHJvSFdJQzVlQjFrU1RhM2F3dG16U0RWMUtmVVJ5aDFRd2daTzNmMWtqZHQycnhDZ1RNWHd1UHRiaw?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Wed, 22 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "How Viking Therapeutics Inc. (1VT) stock trades after earnings - Market Growth Review & AI Driven Stock Reports - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxQa29tUWhLalNkMkNPVGZaakVERjB2NW9RVjBGYWprbU1SR0lCU24tdXVhRklQQTRXbG1lbG9SdGZEQmFBY0p6dE5KdWp0YkV3TE16RUE1aTVRRUVoRkJUeUJ6eHlnRGV0S3BfT0RtRzdsRTZOak0tUG1nRUV6Yk1zYVl5LTVxdWp0MUJxelMtRXNfNTU3Zjg0VWtTQmw3UQ?oc=5\" target=\"_blank\">How Viking Therapeutics Inc. (1VT) stock trades after earnings - Market Growth Review & AI Driven Stock Reports</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQa29tUWhLalNkMkNPVGZaakVERjB2NW9RVjBGYWprbU1SR0lCU24tdXVhRklQQTRXbG1lbG9SdGZEQmFBY0p6dE5KdWp0YkV3TE16RUE1aTVRRUVoRkJUeUJ6eHlnRGV0S3BfT0RtRzdsRTZOak0tUG1nRUV6Yk1zYVl5LTVxdWp0MUJxelMtRXNfNTU3Zjg0VWtTQmw3UQ?oc=5",
    "source": "newser.com",
    "publish_date": "Sun, 09 Nov 2025 07:19:08 GMT"
  },
  {
    "title": "Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have? - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOV2dJZ1FrYldhRVVjamI3ZTNUSE1UcjZ5Y0JCbzl6dWJ3UlFxQzY1UFA3TF9iaVlWaXV2Tzl1T0FZWmotX2lTMGI4UnBpdXBhMXJ4R3JLRWxDeUJDb3hUcXpfLTJpdUY4b05SSGd0YmdzUV9lSWEyS0xieG1IZkVycWlDc1hNUW9T?oc=5\" target=\"_blank\">Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOV2dJZ1FrYldhRVVjamI3ZTNUSE1UcjZ5Y0JCbzl6dWJ3UlFxQzY1UFA3TF9iaVlWaXV2Tzl1T0FZWmotX2lTMGI4UnBpdXBhMXJ4R3JLRWxDeUJDb3hUcXpfLTJpdUY4b05SSGd0YmdzUV9lSWEyS0xieG1IZkVycWlDc1hNUW9T?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Fri, 17 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics: A Look At The Catalysts Ahead (VKTX) - Seeking Alpha",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxQNkcxSmdLOWtGT2FpU1A4ZE9OZVdOYnhGRWZZZG5NMVB1VHNfQzFIdE5EXzcwdEt3WFRteVpKalM3eGFoZkVmMU9BVWtZTVAxUm5kSnc3bFk1VGRaYmFTNHVYYUw0b293Qnh2X0NvQjZUcG5XUFZkZzhqUlpVdV9raTdpQlRWSVZ0UGJwY1FtRQ?oc=5\" target=\"_blank\">Viking Therapeutics: A Look At The Catalysts Ahead (VKTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQNkcxSmdLOWtGT2FpU1A4ZE9OZVdOYnhGRWZZZG5NMVB1VHNfQzFIdE5EXzcwdEt3WFRteVpKalM3eGFoZkVmMU9BVWtZTVAxUm5kSnc3bFk1VGRaYmFTNHVYYUw0b293Qnh2X0NvQjZUcG5XUFZkZzhqUlpVdV9raTdpQlRWSVZ0UGJwY1FtRQ?oc=5",
    "source": "Seeking Alpha",
    "publish_date": "Tue, 28 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics (NASDAQ: VKTX) to join Stifel NYC and Jefferies London; webcast - Stock Titan",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNanA1X2pPdThPVGhDRGtiMlZpM1M4ZFNMOWZmX1VHZHVQWm5qb1UyN0tpaFlWSEtXa2FUaW4xeUhab1NSSk9wOGk1RGdGcGlVS1F2bkZUTkwwWXVrSmNDWUNvUDVFbDE0WjYyOS1aZHVRcTBlM1llUzVSTThSbTk4OGhaWjRDZjhlRGgwUkkySnlGRG9oOTE1NTVJTExjS0JJR0tzU0gwc19pSVlWMV9B?oc=5\" target=\"_blank\">Viking Therapeutics (NASDAQ: VKTX) to join Stifel NYC and Jefferies London; webcast</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
    "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNanA1X2pPdThPVGhDRGtiMlZpM1M4ZFNMOWZmX1VHZHVQWm5qb1UyN0tpaFlWSEtXa2FUaW4xeUhab1NSSk9wOGk1RGdGcGlVS1F2bkZUTkwwWXVrSmNDWUNvUDVFbDE0WjYyOS1aZHVRcTBlM1llUzVSTThSbTk4OGhaWjRDZjhlRGgwUkkySnlGRG9oOTE1NTVJTExjS0JJR0tzU0gwc19pSVlWMV9B?oc=5",
    "source": "Stock Titan",
    "publish_date": "Tue, 04 Nov 2025 21:05:00 GMT"
  },
  {
    "title": "Viking Therapeutics (VKTX): Exploring Valuation as Investor Optimism Grows for Obesity Drug Pipeline and Earnings Release - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxPbkd0TVlodkxrTzJWeGtDT05DNmNlbzVNeVgwWTFYVzhyUGdOaUNSOG1CeXh4YjRJcmoyN0NfR1ZNQmFkYUdZTnYwa2tCRE5BUC1oUDEtOFlZMkZiZzR6akUwUWhOa1NJVndVQ2lQZ3JVbFg0ZEhVdUg1RkdlbkRQV2NYTlljOHpsZEpxTDkxWjVHM2JO?oc=5\" target=\"_blank\">Viking Therapeutics (VKTX): Exploring Valuation as Investor Optimism Grows for Obesity Drug Pipeline and Earnings Release</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPbkd0TVlodkxrTzJWeGtDT05DNmNlbzVNeVgwWTFYVzhyUGdOaUNSOG1CeXh4YjRJcmoyN0NfR1ZNQmFkYUdZTnYwa2tCRE5BUC1oUDEtOFlZMkZiZzR6akUwUWhOa1NJVndVQ2lQZ3JVbFg0ZEhVdUg1RkdlbkRQV2NYTlljOHpsZEpxTDkxWjVHM2JO?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Sun, 19 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics (VKTX): Assessing Valuation After Shares Jump 28% in the Past Month - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxQQ2Fqc3BLT3M2SWRpY1RkU09pd3lPY29zR2NVNFR3SmtiNDd5cU92ZlBIQWVLRGdDTHZyNG1TeHpQMTA4ckp3U0M1UWxXZmpUekZYeWNfOXVQVHZKNGNHVFlGTUh4M2thMm9qLXRZcnVCSjFXTkx4c2tVdVhDeFZiSExIVGlYR0htYWhrU0s4dDJ5NGk0?oc=5\" target=\"_blank\">Viking Therapeutics (VKTX): Assessing Valuation After Shares Jump 28% in the Past Month</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQQ2Fqc3BLT3M2SWRpY1RkU09pd3lPY29zR2NVNFR3SmtiNDd5cU92ZlBIQWVLRGdDTHZyNG1TeHpQMTA4ckp3U0M1UWxXZmpUekZYeWNfOXVQVHZKNGNHVFlGTUh4M2thMm9qLXRZcnVCSjFXTkx4c2tVdVhDeFZiSExIVGlYR0htYWhrU0s4dDJ5NGk0?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Sun, 02 Nov 2025 21:14:00 GMT"
  },
  {
    "title": "Weight-Loss Drugs Are Hot. Only One Stock Is. - Investor's Business Daily",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxPTVU1OVdvdXhnU3hlY0I1QW1rbTdKdXhnakpPR21wM1NKSzVmOTVMS29TT2VKYjZQLTY2Y3lqUUxCeHNWRklma215Z3FsSmJiVHk3WEZXV0RWU0NIcE0xampaZWdHQ01PN0lwN3l6WHpHQlMwUnl6dFNvenM5ZjJWME9jRURtV2o2Q3ptTnZVWS1xcTBIY2Y0?oc=5\" target=\"_blank\">Weight-Loss Drugs Are Hot. Only One Stock Is.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
    "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPTVU1OVdvdXhnU3hlY0I1QW1rbTdKdXhnakpPR21wM1NKSzVmOTVMS29TT2VKYjZQLTY2Y3lqUUxCeHNWRklma215Z3FsSmJiVHk3WEZXV0RWU0NIcE0xampaZWdHQ01PN0lwN3l6WHpHQlMwUnl6dFNvenM5ZjJWME9jRURtV2o2Q3ptTnZVWS1xcTBIY2Y0?oc=5",
    "source": "Investor's Business Daily",
    "publish_date": "Fri, 07 Nov 2025 16:22:00 GMT"
  },
  {
    "title": "Viking Therapeutics (NASDAQ: VKTX) says VK2735 cut weight up to 14.7% in 13 weeks - Stock Titan",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNZ0F3S0luSGJRUU5pUm1nWWtORXNqa1lmQ1JqMk9QajVMbHpYV3BHYzhHMms3WENZdDNnWkkwY1ExOHpVTUhWd3RJUHlHQk52a1pNcUt2NEgzSmNyeGFvZ2RmSXRodlMyQThlaVlKeHFXckNDcGc1ajFDRTh3WmFqdG5xM0pHdGZvTzIya3RBU0didmR5c2ozRllOaGpVRXA2M2dEdUZ3azFFSW8xRWtIblJwMHd5a1pBQ3k4?oc=5\" target=\"_blank\">Viking Therapeutics (NASDAQ: VKTX) says VK2735 cut weight up to 14.7% in 13 weeks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
    "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNZ0F3S0luSGJRUU5pUm1nWWtORXNqa1lmQ1JqMk9QajVMbHpYV3BHYzhHMms3WENZdDNnWkkwY1ExOHpVTUhWd3RJUHlHQk52a1pNcUt2NEgzSmNyeGFvZ2RmSXRodlMyQThlaVlKeHFXckNDcGc1ajFDRTh3WmFqdG5xM0pHdGZvTzIya3RBU0didmR5c2ozRllOaGpVRXA2M2dEdUZ3azFFSW8xRWtIblJwMHd5a1pBQ3k4?oc=5",
    "source": "Stock Titan",
    "publish_date": "Thu, 06 Nov 2025 12:05:00 GMT"
  },
  {
    "title": "Why Viking Therapeutics Inc. stock could see breakout soon - Market Sentiment Report & Daily Stock Trend Reports - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxQZ1pNaDJiZVZ6cDZQTXZuOGtVdEtvQXNPVnBtMXFfcFhiZnc0VTdMSzlfcGdZWGgxNkkzYXJYSmYzRUF0ZS1jSlBBQm9OWUY0S0l5ME5NTlBIQ1hMUjRQNHRtYlROMEVEbkNlYzB5WXdVRVVTN0FMWktWdEZlcGlQYUpDeHVYeFJIZ1hZaGN2SWxQd3NBRWdEWUd3?oc=5\" target=\"_blank\">Why Viking Therapeutics Inc. stock could see breakout soon - Market Sentiment Report & Daily Stock Trend Reports</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQZ1pNaDJiZVZ6cDZQTXZuOGtVdEtvQXNPVnBtMXFfcFhiZnc0VTdMSzlfcGdZWGgxNkkzYXJYSmYzRUF0ZS1jSlBBQm9OWUY0S0l5ME5NTlBIQ1hMUjRQNHRtYlROMEVEbkNlYzB5WXdVRVVTN0FMWktWdEZlcGlQYUpDeHVYeFJIZ1hZaGN2SWxQd3NBRWdEWUd3?oc=5",
    "source": "newser.com",
    "publish_date": "Fri, 07 Nov 2025 08:32:57 GMT"
  },
  {
    "title": "Viking Therapeutics (VKTX) Receives a Buy from Oppenheimer - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPLWltQlhlbmw1SDEtMFhSbkM0THhSMHBieHFBNVgzOHZlQ2d0Q01mMGUyMVF4UW9NZk9JaVg0ZExWeEhPTi04cThqMnotcklJNXljNXQtMkp0ZWZOZWNpdlFfeWV5eVV4NXg4U214c1lHQXZ4dGpYTzl3QURuYlhJQlA1c2FVVmJyV1lB?oc=5\" target=\"_blank\">Viking Therapeutics (VKTX) Receives a Buy from Oppenheimer</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPLWltQlhlbmw1SDEtMFhSbkM0THhSMHBieHFBNVgzOHZlQ2d0Q01mMGUyMVF4UW9NZk9JaVg0ZExWeEhPTi04cThqMnotcklJNXljNXQtMkp0ZWZOZWNpdlFfeWV5eVV4NXg4U214c1lHQXZ4dGpYTzl3QURuYlhJQlA1c2FVVmJyV1lB?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Fri, 17 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Is Viking\u2019s (VKTX) Upcoming VK2735 Data Release Shifting Its Position in Obesity Drug Innovation? - simplywall.st",
    "content": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Is Viking\u2019s (VKTX) Upcoming VK2735 Data Release Shifting Its Position in Obesity Drug Innovation?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
    "url": "https://news.google.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?oc=5",
    "source": "simplywall.st",
    "publish_date": "Thu, 06 Nov 2025 05:44:07 GMT"
  },
  {
    "title": "Did Viking Therapeutics Just Say \"Checkmate\" to Eli Lilly? - The Motley Fool",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxOdjYzelcxNjRWTTV0ekN5SUhYeVJLSnVOLUd1bzBZdVBHWVNWVGtfR3dacE91dHVCLTdtOC1jd19OREFoaThqeU5ra1poS0NvNUt0c0lfMndLSE1qV3hMbVh4NTZNbHU1aVVmUVNhOVFHTlZqZS14RW9BNnVLTTVxRWpCbVJpb1lKVnRpTWhINDJWa1hNR1hZ?oc=5\" target=\"_blank\">Did Viking Therapeutics Just Say \"Checkmate\" to Eli Lilly?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
    "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOdjYzelcxNjRWTTV0ekN5SUhYeVJLSnVOLUd1bzBZdVBHWVNWVGtfR3dacE91dHVCLTdtOC1jd19OREFoaThqeU5ra1poS0NvNUt0c0lfMndLSE1qV3hMbVh4NTZNbHU1aVVmUVNhOVFHTlZqZS14RW9BNnVLTTVxRWpCbVJpb1lKVnRpTWhINDJWa1hNR1hZ?oc=5",
    "source": "The Motley Fool",
    "publish_date": "Thu, 16 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Is Viking Therapeutics Inc. forming a bottoming base - 2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxPUGJfdlNHU3ltU01HamRoejFOcG5yMU5UYWZBSmNlSHZEOXRwbTd5RkZzb1c2dHRmellBYUluNnhIdTZtbVhYQTFXNVZlaTZUcFlWUlJUa09NN0ZLNE1jeHhOeXhIelZPMzZ5czJwYUNVN3pBazFYRlVRU3ZHMFRfeEx6YnFSc2RLemFHQy1FaVBldw?oc=5\" target=\"_blank\">Is Viking Therapeutics Inc. forming a bottoming base - 2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPUGJfdlNHU3ltU01HamRoejFOcG5yMU5UYWZBSmNlSHZEOXRwbTd5RkZzb1c2dHRmellBYUluNnhIdTZtbVhYQTFXNVZlaTZUcFlWUlJUa09NN0ZLNE1jeHhOeXhIelZPMzZ5czJwYUNVN3pBazFYRlVRU3ZHMFRfeEx6YnFSc2RLemFHQy1FaVBldw?oc=5",
    "source": "newser.com",
    "publish_date": "Thu, 06 Nov 2025 06:20:53 GMT"
  },
  {
    "title": "Viking Therapeutics\u2019 VK2735 Trials and Strategic Positioning Drive Buy Rating - TipRanks",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxOR2hGU0U3bG5CV3U5TTJBNzkwWDh6NGRIclBxQmpabWVOUjdHVDdVQ1dJWFE3c3JyTWluM0JhMV9ZeGRBS3dFbEtpaEV4YS1iaWJGOVFrZkZuSW1aUGNGV212ZGFMTF8wek1jeDFGTWh4aVhlMzhEbi1xeEJKUWZqLUtPS3AzcmUyRndfSU9ydkVucG0tOFNOM1dhN2FmaUtrd2ljU1NHNXhtN2k5SkdQN0hpeHpMQ0p6bktVVW9zaw?oc=5\" target=\"_blank\">Viking Therapeutics\u2019 VK2735 Trials and Strategic Positioning Drive Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
    "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOR2hGU0U3bG5CV3U5TTJBNzkwWDh6NGRIclBxQmpabWVOUjdHVDdVQ1dJWFE3c3JyTWluM0JhMV9ZeGRBS3dFbEtpaEV4YS1iaWJGOVFrZkZuSW1aUGNGV212ZGFMTF8wek1jeDFGTWh4aVhlMzhEbi1xeEJKUWZqLUtPS3AzcmUyRndfSU9ydkVucG0tOFNOM1dhN2FmaUtrd2ljU1NHNXhtN2k5SkdQN0hpeHpMQ0p6bktVVW9zaw?oc=5",
    "source": "TipRanks",
    "publish_date": "Thu, 06 Nov 2025 23:27:26 GMT"
  },
  {
    "title": "Viking Therapeutics Stock (VKTX) Opinions on Phase 3 Trial Progress and Drug Data - Quiver Quantitative",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiugFBVV95cUxNbHo0dTl6MTc4VmRKR29nc1dDY1hrRXVrakNlMm1GMlVCT2J4QWVPUmROZnZ3OUlEamZ4aEN1aDlzbU9ZbjZfSE1ZRmZHd1NUOUluSFBSczVYOFk0R0F3WEl4Q0U1MlFEaXRabHhIY0pEUDJSc05LMXo3RU11R29samp0TXZrQVlaRjJVVWltbVJNd2Z0NDJja1JIWEtEaF9LYzhxZ1d1Z1JfTXQxUmU0TVFEU3UwS1VocVE?oc=5\" target=\"_blank\">Viking Therapeutics Stock (VKTX) Opinions on Phase 3 Trial Progress and Drug Data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Quiver Quantitative</font>",
    "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNbHo0dTl6MTc4VmRKR29nc1dDY1hrRXVrakNlMm1GMlVCT2J4QWVPUmROZnZ3OUlEamZ4aEN1aDlzbU9ZbjZfSE1ZRmZHd1NUOUluSFBSczVYOFk0R0F3WEl4Q0U1MlFEaXRabHhIY0pEUDJSc05LMXo3RU11R29samp0TXZrQVlaRjJVVWltbVJNd2Z0NDJja1JIWEtEaF9LYzhxZ1d1Z1JfTXQxUmU0TVFEU3UwS1VocVE?oc=5",
    "source": "Quiver Quantitative",
    "publish_date": "Wed, 29 Oct 2025 14:06:00 GMT"
  },
  {
    "title": "Viking Therapeutics Q3 Earnings: What We Learned (And Why We Should Keep Faith) (VKTX) - Seeking Alpha",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQktMTDRGamQ1d2dSNmhvdjItN1N3YVpoU0ZGNkIxYXFpX1NEMWd1NnBvNllDMk96c3FmZ1VjVEgza2pFNWh1M05DMXhkd3JsalFKZ2lRY01vZnAxbkozS1U3ZGpnYkpza0hoOE1xZlhNUmZQNi1DcWg2MjNTN2RSYjVKZkh4SVNPYW5mbkRLRnFlT1BRUGotMFNobHVwX1hHY1ZTX1Vldm16UnJnQ19pLWpCNmVxVjhx?oc=5\" target=\"_blank\">Viking Therapeutics Q3 Earnings: What We Learned (And Why We Should Keep Faith) (VKTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQktMTDRGamQ1d2dSNmhvdjItN1N3YVpoU0ZGNkIxYXFpX1NEMWd1NnBvNllDMk96c3FmZ1VjVEgza2pFNWh1M05DMXhkd3JsalFKZ2lRY01vZnAxbkozS1U3ZGpnYkpza0hoOE1xZlhNUmZQNi1DcWg2MjNTN2RSYjVKZkh4SVNPYW5mbkRLRnFlT1BRUGotMFNobHVwX1hHY1ZTX1Vldm16UnJnQ19pLWpCNmVxVjhx?oc=5",
    "source": "Seeking Alpha",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Is Viking Therapeutics Inc. stock a buy before product launches - July 2025 Rallies & Real-Time Volume Spike Alerts - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxQdTVja0RHdy1nM2FFbk5WVlVLOEgyMUlOSzJMblhpQ0swWllMVGs2OEZZYWdodWNUbmVhaUpmZ2JnYXBOWVBicFN1M09iOEVHaW92TC1jRmZFeHI2bWFqeTlrUnhJUDVFSDlhWjk4akhaaFBMaXhabmNSYVRqZ2txX2I1bEwwUjBFSDRWb3NJNUFOOFlXU2JIVFd1YVQ3cWc?oc=5\" target=\"_blank\">Is Viking Therapeutics Inc. stock a buy before product launches - July 2025 Rallies & Real-Time Volume Spike Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQdTVja0RHdy1nM2FFbk5WVlVLOEgyMUlOSzJMblhpQ0swWllMVGs2OEZZYWdodWNUbmVhaUpmZ2JnYXBOWVBicFN1M09iOEVHaW92TC1jRmZFeHI2bWFqeTlrUnhJUDVFSDlhWjk4akhaaFBMaXhabmNSYVRqZ2txX2I1bEwwUjBFSDRWb3NJNUFOOFlXU2JIVFd1YVQ3cWc?oc=5",
    "source": "newser.com",
    "publish_date": "Fri, 07 Nov 2025 06:43:22 GMT"
  },
  {
    "title": "What makes Viking Therapeutics Inc. stock attractive to growth funds - 2025 Big Picture & Free Safe Capital Growth Stock Tips - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRm5qOHk3NXRfV0ZYUVhwRFZmNFJ0WHBlUHpvREN2RnlQYW92UExEMmM1WXFzdXRBYWpsUnA2My1VOExaRFhNS3QzbzRfZkFTVl9jTFpLeHQ2YnVfdnZUR0FnTGcwRFNNTTgtRmxzcDRQUmpmZVgxV3hTaE9nM3VmOU9TRUZWeHhJWEREVHNZOWwzNU5wQ2g3MUQwb2VRamQyQS0yeU53?oc=5\" target=\"_blank\">What makes Viking Therapeutics Inc. stock attractive to growth funds - 2025 Big Picture & Free Safe Capital Growth Stock Tips</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQRm5qOHk3NXRfV0ZYUVhwRFZmNFJ0WHBlUHpvREN2RnlQYW92UExEMmM1WXFzdXRBYWpsUnA2My1VOExaRFhNS3QzbzRfZkFTVl9jTFpLeHQ2YnVfdnZUR0FnTGcwRFNNTTgtRmxzcDRQUmpmZVgxV3hTaE9nM3VmOU9TRUZWeHhJWEREVHNZOWwzNU5wQ2g3MUQwb2VRamQyQS0yeU53?oc=5",
    "source": "newser.com",
    "publish_date": "Fri, 07 Nov 2025 05:24:25 GMT"
  },
  {
    "title": "Viking Therapeutics to Participate at Upcoming Investor Conferences - Barchart.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQUkRGcFBSaDI4aWFMNkxmNWJnMGFURWlVOXJqX25kWUlMcmNwaGdwNl9PbmR6TE1wZTUyeUJGX2I2Q1lpQ0ZsZEhMLTRuR1pNa3lXaWJyN1FrMWZxVU5WS0lzRzNzZHplQTJjRHh6ZVVsLUF2bnBlUTNuQ244Sjl3YWYyZ3ZPUjVYZWdmblpSZWIzdWNXNDFvVEdCanlKTVhEMU44MktvRU5oQlZYUnVmVGtn?oc=5\" target=\"_blank\">Viking Therapeutics to Participate at Upcoming Investor Conferences</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barchart.com</font>",
    "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQUkRGcFBSaDI4aWFMNkxmNWJnMGFURWlVOXJqX25kWUlMcmNwaGdwNl9PbmR6TE1wZTUyeUJGX2I2Q1lpQ0ZsZEhMLTRuR1pNa3lXaWJyN1FrMWZxVU5WS0lzRzNzZHplQTJjRHh6ZVVsLUF2bnBlUTNuQ244Sjl3YWYyZ3ZPUjVYZWdmblpSZWIzdWNXNDFvVEdCanlKTVhEMU44MktvRU5oQlZYUnVmVGtn?oc=5",
    "source": "Barchart.com",
    "publish_date": "Tue, 04 Nov 2025 21:05:00 GMT"
  },
  {
    "title": "Viking Therapeutics, Inc. (VKTX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxNcC1MOHhJeDh5MU10a0VfWV90RWRmSXdlRTE2b1VBMlByRmlJTjFoYXpuc0tIRmVYUVRXMUhuaEEzejY4Nl9fMFJKUGZhSFhtaW5Wdkx4Wm1hQU1CcVQ5TW5pSnVocF9ZTDUxcGoxRG1jNXhJSUNoVjNFeWo5YUFSRHE5VDZvU28yNDdKUg?oc=5\" target=\"_blank\">Viking Therapeutics, Inc. (VKTX) Registers a Bigger Fall Than the Market: Important Facts to Note</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNcC1MOHhJeDh5MU10a0VfWV90RWRmSXdlRTE2b1VBMlByRmlJTjFoYXpuc0tIRmVYUVRXMUhuaEEzejY4Nl9fMFJKUGZhSFhtaW5Wdkx4Wm1hQU1CcVQ5TW5pSnVocF9ZTDUxcGoxRG1jNXhJSUNoVjNFeWo5YUFSRHE5VDZvU28yNDdKUg?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Tue, 14 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics (VKTX) Reports Positive Phase 2 Results for VK2735 - GuruFocus",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNW96bVZUcXVLMHprbk84bzBuVWVHRm5XdWNreHRjQ3BFNExIS2JLR2llZmlJYk1TZWNuUUc0SFE0Ri1wcWc0dzM1UEc1ZnVYUEM1MmhIOENmQ0lJd1hvTjZSV2RJVHBINGpyb2p3VE1xeGpldmZaeUZaRXZYUTNOX2Y0cGhyQW9hUDRjcDI2eTJiYzdndXJBSFBGQWx4ei1WSG1BQkdxWFozWFpsX2xnVllHeFRKeVVraDFN?oc=5\" target=\"_blank\">Viking Therapeutics (VKTX) Reports Positive Phase 2 Results for VK2735</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
    "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNW96bVZUcXVLMHprbk84bzBuVWVHRm5XdWNreHRjQ3BFNExIS2JLR2llZmlJYk1TZWNuUUc0SFE0Ri1wcWc0dzM1UEc1ZnVYUEM1MmhIOENmQ0lJd1hvTjZSV2RJVHBINGpyb2p3VE1xeGpldmZaeUZaRXZYUTNOX2Y0cGhyQW9hUDRjcDI2eTJiYzdndXJBSFBGQWx4ei1WSG1BQkdxWFozWFpsX2xnVllHeFRKeVVraDFN?oc=5",
    "source": "GuruFocus",
    "publish_date": "Thu, 06 Nov 2025 18:04:56 GMT"
  },
  {
    "title": "Signal strength of Viking Therapeutics Inc. stock in tech scanners - Weekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNa2ZZcm12VWhQTnFHY21YSHNSQ3o4bTJnd1o1R1BGTjZKMDJpVGhYQk1zNFBaUWZsRUpNWVh6RjNtZXQzVTIyeFJteEdFQy1aQ2c1dGRzQTJvMjVUMTNlWThHcGxzRGhZckVUMWhrc3BjeVJNMUN5YmlCY0Z4VmlqV1VrNFBpSS0yRllaeVZsS2NBV05wVkgwRnE1S3BFR2NocU9XcQ?oc=5\" target=\"_blank\">Signal strength of Viking Therapeutics Inc. stock in tech scanners - Weekly Trading Summary & Advanced Swing Trade Entry Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNa2ZZcm12VWhQTnFHY21YSHNSQ3o4bTJnd1o1R1BGTjZKMDJpVGhYQk1zNFBaUWZsRUpNWVh6RjNtZXQzVTIyeFJteEdFQy1aQ2c1dGRzQTJvMjVUMTNlWThHcGxzRGhZckVUMWhrc3BjeVJNMUN5YmlCY0Z4VmlqV1VrNFBpSS0yRllaeVZsS2NBV05wVkgwRnE1S3BFR2NocU9XcQ?oc=5",
    "source": "newser.com",
    "publish_date": "Wed, 05 Nov 2025 08:02:17 GMT"
  },
  {
    "title": "Heatmap analysis for Viking Therapeutics Inc. and competitors - July 2025 Levels & Expert Verified Movement Alerts - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxPRGZON1RXMU5oWndXWEVSLUhFQlNrYXQ5WWx6Mm53QW41WlJMUTFSUXBPQUJYQm11ZFJqc2NJSTB1cWhBT3cxZERiUmJ3VzRhVV83UlVZbFBqaDd3SU93MW5qd2xfWGxLMW4tS3hCcHRhUzVEQjY0SmRLNzZ4MWJfWHVXUWxCVzRTanVaaFlidHl1THJnWDVGME12LWN2dw?oc=5\" target=\"_blank\">Heatmap analysis for Viking Therapeutics Inc. and competitors - July 2025 Levels & Expert Verified Movement Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPRGZON1RXMU5oWndXWEVSLUhFQlNrYXQ5WWx6Mm53QW41WlJMUTFSUXBPQUJYQm11ZFJqc2NJSTB1cWhBT3cxZERiUmJ3VzRhVV83UlVZbFBqaDd3SU93MW5qd2xfWGxLMW4tS3hCcHRhUzVEQjY0SmRLNzZ4MWJfWHVXUWxCVzRTanVaaFlidHl1THJnWDVGME12LWN2dw?oc=5",
    "source": "newser.com",
    "publish_date": "Wed, 05 Nov 2025 07:36:27 GMT"
  },
  {
    "title": "Can Viking Therapeutics Inc. stock hit record highs again - Trade Volume Report & Free Technical Confirmation Trade Alerts - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxNeUo0YW1ralJ2M3dFMWFzNmVwRFF2SWFmUGVNc0hOU2Q1SzN3Rm04VVhEU0NVZGJlQXRBcnJwNlU1OUV5bTNoQXVNVHNMV193X2tod3RYQ0tTaWlydXdMVkMyQnlhaDNJalZab2d4dTVicDNjcGVHYjlNWC1DNWtoSXlNX20xdEFTWC1pcmlsb0xSTDRuMm1rdw?oc=5\" target=\"_blank\">Can Viking Therapeutics Inc. stock hit record highs again - Trade Volume Report & Free Technical Confirmation Trade Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNeUo0YW1ralJ2M3dFMWFzNmVwRFF2SWFmUGVNc0hOU2Q1SzN3Rm04VVhEU0NVZGJlQXRBcnJwNlU1OUV5bTNoQXVNVHNMV193X2tod3RYQ0tTaWlydXdMVkMyQnlhaDNJalZab2d4dTVicDNjcGVHYjlNWC1DNWtoSXlNX20xdEFTWC1pcmlsb0xSTDRuMm1rdw?oc=5",
    "source": "newser.com",
    "publish_date": "Wed, 05 Nov 2025 09:01:40 GMT"
  },
  {
    "title": "Where is Viking Therapeutics (VKTX) Headed According to Analysts? - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNblZvdlhYRXVoOEtzNl95OGZseXdlb2lqVHk3MGdTQ2JwV3V4NUMwdHhqVm5XekE5VXotenRDWnl3N19xajA4TGZNdU03T1p1WWZNQkNNNmUtVlB1c19IRUtVOUxpcXF4WGR6Z0k2dW1NVzY4dzNWVkYycndiMlRMdjJ0cGNLYThzbVpV?oc=5\" target=\"_blank\">Where is Viking Therapeutics (VKTX) Headed According to Analysts?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNblZvdlhYRXVoOEtzNl95OGZseXdlb2lqVHk3MGdTQ2JwV3V4NUMwdHhqVm5XekE5VXotenRDWnl3N19xajA4TGZNdU03T1p1WWZNQkNNNmUtVlB1c19IRUtVOUxpcXF4WGR6Z0k2dW1NVzY4dzNWVkYycndiMlRMdjJ0cGNLYThzbVpV?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Tue, 07 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? - The Motley Fool",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPZWtWcXBXTVQxaFVtcmwycXJaaV9reXFqZmNiXzNPblVVR1hxRGZYZXVybHhvLTlzR192TEx3LW82MlV5ZEZfbGFhZXFJcjd0RVMzb3JQVmpUbzVMc2RVX2RqeVJ5Z09GaENxSkpZSzRSY0xqNFNfcTFVS2J1V3NhTWdUcDJHek5SeTBfR3N3QXVHR0ZIaUxiUw?oc=5\" target=\"_blank\">Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
    "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPZWtWcXBXTVQxaFVtcmwycXJaaV9reXFqZmNiXzNPblVVR1hxRGZYZXVybHhvLTlzR192TEx3LW82MlV5ZEZfbGFhZXFJcjd0RVMzb3JQVmpUbzVMc2RVX2RqeVJ5Z09GaENxSkpZSzRSY0xqNFNfcTFVS2J1V3NhTWdUcDJHek5SeTBfR3N3QXVHR0ZIaUxiUw?oc=5",
    "source": "The Motley Fool",
    "publish_date": "Fri, 17 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPQmxHeTc2SVcydmxzZW5WRG9pZF9xTVJRSW9xNDdWQ0dvZGJpVDBORFQ1OG9hWFFtaXNyNk1UNTJkamlLYUUzMXRza25xNDhxdkwxQndqTml3a0s2cXVJNnFBajhtUHV0cjNpejRieVYzejNQZ2lzeGsyTmVXejVHU2FDRWkwakU?oc=5\" target=\"_blank\">Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPQmxHeTc2SVcydmxzZW5WRG9pZF9xTVJRSW9xNDdWQ0dvZGJpVDBORFQ1OG9hWFFtaXNyNk1UNTJkamlLYUUzMXRza25xNDhxdkwxQndqTml3a0s2cXVJNnFBajhtUHV0cjNpejRieVYzejNQZ2lzeGsyTmVXejVHU2FDRWkwakU?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Fri, 17 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics to Participate at Upcoming Investor Conferences \u2013 Company Announcement - Financial Times",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxNZHlXdTU1eUd1ZWlQaW8xWmpzZERyOGJpUnVGckx0eVBDdFNBMG5kMHhsOVYzcXRNR0R2b2M2MzRxU2hJLTdLQm15c0UtQmE1WktFZHQ0MGhiV3ZtYy1LNzJ2cWtEeVdrQ1M0M2tqRTdKUXdkOU1GMUJrd1Y1RVk5NXRLbWxDYVhONHRxcXJNU2l6OEN0LUE?oc=5\" target=\"_blank\">Viking Therapeutics to Participate at Upcoming Investor Conferences \u2013 Company Announcement</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Financial Times</font>",
    "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNZHlXdTU1eUd1ZWlQaW8xWmpzZERyOGJpUnVGckx0eVBDdFNBMG5kMHhsOVYzcXRNR0R2b2M2MzRxU2hJLTdLQm15c0UtQmE1WktFZHQ0MGhiV3ZtYy1LNzJ2cWtEeVdrQ1M0M2tqRTdKUXdkOU1GMUJrd1Y1RVk5NXRLbWxDYVhONHRxcXJNU2l6OEN0LUE?oc=5",
    "source": "Financial Times",
    "publish_date": "Tue, 04 Nov 2025 21:05:00 GMT"
  },
  {
    "title": "Viking Therapeutics Stock Soars After Morgan Stanley\u2019s Price Target Implies A Potential 225% Upside - Stocktwits",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPY2xOUzVnclphdUNHNVlSZHE0cWItQktCTFRIYVduOFhyUUVnVUoxSnRCbXppcF91MmdNVFRSXzVFZC1LNE5XNVhlaGJ1dGlZSklicWZIQmFtMXBtRDNISFdjZFpIbHhnSUlMbFpVMkczREhqem9OLUFHUndxeElSZ1JMSURSYjFrREhoVldVSzNBTDd4eHEyUVVSZmJFbUg5d0dwbVFzMUxPbHpPRmtGOVc0QnR3eklWOWN4VmtwLWlER1JpZnB2VDBmOUViTm5WTEtiT3YyLU1YZk9JU1liMERGamE2MThZc051RA?oc=5\" target=\"_blank\">Viking Therapeutics Stock Soars After Morgan Stanley\u2019s Price Target Implies A Potential 225% Upside</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stocktwits</font>",
    "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPY2xOUzVnclphdUNHNVlSZHE0cWItQktCTFRIYVduOFhyUUVnVUoxSnRCbXppcF91MmdNVFRSXzVFZC1LNE5XNVhlaGJ1dGlZSklicWZIQmFtMXBtRDNISFdjZFpIbHhnSUlMbFpVMkczREhqem9OLUFHUndxeElSZ1JMSURSYjFrREhoVldVSzNBTDd4eHEyUVVSZmJFbUg5d0dwbVFzMUxPbHpPRmtGOVc0QnR3eklWOWN4VmtwLWlER1JpZnB2VDBmOUViTm5WTEtiT3YyLU1YZk9JU1liMERGamE2MThZc051RA?oc=5",
    "source": "Stocktwits",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Down 44%, Should You Buy the Dip on Viking Therapeutics? - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTFBBdVhteFMydFJud0d1RkNsVHZGVDFmWnM2TVJqTTVQSDZ0WmdScGQweHdDNnhGRVZVRGtQTUVyM3p5YjVpSlpYX09VMHRkQU1hcjdfWHZaOUM4VTFhVW50RUZVdThiYUluWTVqNmlxSy1BT2tDU0dB?oc=5\" target=\"_blank\">Down 44%, Should You Buy the Dip on Viking Therapeutics?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFBBdVhteFMydFJud0d1RkNsVHZGVDFmWnM2TVJqTTVQSDZ0WmdScGQweHdDNnhGRVZVRGtQTUVyM3p5YjVpSlpYX09VMHRkQU1hcjdfWHZaOUM4VTFhVW50RUZVdThiYUluWTVqNmlxSy1BT2tDU0dB?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Mon, 13 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "How Viking Therapeutics Inc. (1VT) stock trades after earnings - 2025 Biggest Moves & Community Consensus Picks - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOaE9NdUVNcTk4YmpGaVJrZlExYks4am1iRktFbFkxLXJ6c3RyZG52dV9vLXpSdTNNQ2FOb2NaRjVvMWhkcnplU3BOUV84cDRyelNiUHF4YnBaTjNzMGZJVGhyTHV5UTh1bjlIbUtHQWtBTmtZUnFKdy0xYTN4S0k5WTZjNURNNmlRekVhWWZUUk9ta3dWT3lvR3ZOYlNaUQ?oc=5\" target=\"_blank\">How Viking Therapeutics Inc. (1VT) stock trades after earnings - 2025 Biggest Moves & Community Consensus Picks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOaE9NdUVNcTk4YmpGaVJrZlExYks4am1iRktFbFkxLXJ6c3RyZG52dV9vLXpSdTNNQ2FOb2NaRjVvMWhkcnplU3BOUV84cDRyelNiUHF4YnBaTjNzMGZJVGhyTHV5UTh1bjlIbUtHQWtBTmtZUnFKdy0xYTN4S0k5WTZjNURNNmlRekVhWWZUUk9ta3dWT3lvR3ZOYlNaUQ?oc=5",
    "source": "newser.com",
    "publish_date": "Thu, 06 Nov 2025 08:20:37 GMT"
  },
  {
    "title": "What makes Viking Therapeutics Inc. stock attractive to growth funds - Price Action & Daily Stock Momentum Reports - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxQcWlWM05jdzNXb1RUTU92RnRZQjlPT3NnWV9TRUpCMkZwU1dnbk1CRTBjTndCdlhTWjJwREV3NHVoYURJd0NNNjJPSjlvMk1CXy1wRkNTOEpvVXpMZXdISzY1WG9SVUUwWWNtOVlsRklHMS1iTE50WHNldGlxd3VkUnJ3eElXYXpyRVV3alg3azVCWVlfTVBFZjhnZ3oxWnB0MGJYRUFB?oc=5\" target=\"_blank\">What makes Viking Therapeutics Inc. stock attractive to growth funds - Price Action & Daily Stock Momentum Reports</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQcWlWM05jdzNXb1RUTU92RnRZQjlPT3NnWV9TRUpCMkZwU1dnbk1CRTBjTndCdlhTWjJwREV3NHVoYURJd0NNNjJPSjlvMk1CXy1wRkNTOEpvVXpMZXdISzY1WG9SVUUwWWNtOVlsRklHMS1iTE50WHNldGlxd3VkUnJ3eElXYXpyRVV3alg3azVCWVlfTVBFZjhnZ3oxWnB0MGJYRUFB?oc=5",
    "source": "newser.com",
    "publish_date": "Thu, 06 Nov 2025 02:55:44 GMT"
  },
  {
    "title": "Advanced analytics toolkit walkthrough for Viking Therapeutics Inc. - Stock Surge & Reliable Price Breakout Signals - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxPdEdraWpud0ZqZjhVdkVQS01KdjZwS1FZY1JWV3JrSnhQbnRtRVNLTHp0ZDZPby1ZclZnbHdCNEp2S0Q0MjBsbjZZbkRmTmp2eWxKRnhZdG15ZjBtVVdvaWpCSkFLWFF5VnJITUVrQzR1ZGE1alRhRlpxeVRqX215Mjg3eEpBRUxJOEhPcHZ0OUVMSVdHR2tvalVyeldYN1lWLU1xYw?oc=5\" target=\"_blank\">Advanced analytics toolkit walkthrough for Viking Therapeutics Inc. - Stock Surge & Reliable Price Breakout Signals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPdEdraWpud0ZqZjhVdkVQS01KdjZwS1FZY1JWV3JrSnhQbnRtRVNLTHp0ZDZPby1ZclZnbHdCNEp2S0Q0MjBsbjZZbkRmTmp2eWxKRnhZdG15ZjBtVVdvaWpCSkFLWFF5VnJITUVrQzR1ZGE1alRhRlpxeVRqX215Mjg3eEpBRUxJOEhPcHZ0OUVMSVdHR2tvalVyeldYN1lWLU1xYw?oc=5",
    "source": "newser.com",
    "publish_date": "Thu, 06 Nov 2025 05:17:32 GMT"
  },
  {
    "title": "Viking Therapeutics, Inc. (VKTX) Stock: Jumps as New Obesity Drug Data Shows Strong Metabolic Improvements - parameter.io",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNYlZRbVFjenB5Y084ZXFPTFV2QjR5MS1hTkdGbkV5em82M3hacXdQUXBDTmZ5cnZxQVJmYk9scDdmLWRKeXlOUFViWE04WGJ3RlRnZFZ3THJHY3RnaTRKTFFkVzcySG1tdnAwSlpEdUw2S1ZfM3RnYTltWUoyVVd6bXk5S2loenB2NGY3X1JSZkZhSW1Pb3dQdkNUU1JjWG9FTlNjM2JQNDFoWVZzYkdXLVNNUXRvYnhkRG95N2hDQ0U?oc=5\" target=\"_blank\">Viking Therapeutics, Inc. (VKTX) Stock: Jumps as New Obesity Drug Data Shows Strong Metabolic Improvements</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">parameter.io</font>",
    "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNYlZRbVFjenB5Y084ZXFPTFV2QjR5MS1hTkdGbkV5em82M3hacXdQUXBDTmZ5cnZxQVJmYk9scDdmLWRKeXlOUFViWE04WGJ3RlRnZFZ3THJHY3RnaTRKTFFkVzcySG1tdnAwSlpEdUw2S1ZfM3RnYTltWUoyVVd6bXk5S2loenB2NGY3X1JSZkZhSW1Pb3dQdkNUU1JjWG9FTlNjM2JQNDFoWVZzYkdXLVNNUXRvYnhkRG95N2hDQ0U?oc=5",
    "source": "parameter.io",
    "publish_date": "Thu, 06 Nov 2025 20:21:03 GMT"
  },
  {
    "title": "Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have? - Zacks Investment Research",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNVFpJb0xLV01LZmI1MzctOVkzaWNSNE9haUVpU3ZzcERtWlVJdGtvb25rUFg1YUlzRTNqTmRtcDN3Rlg5OUxvM3VJWGRlaWtRMHVfcTBGeWJJUFY4SW5EZ0xmLUNOLVZkV0VPdThmVXJVZ0ZYeWdDMnRlNElMYkZfWllUTVBKbE5zZzVBc1VfdGp5TTk3YkU1aEV3Q3pJZWdOMDhVRVkyc245dWs?oc=5\" target=\"_blank\">Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Zacks Investment Research</font>",
    "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNVFpJb0xLV01LZmI1MzctOVkzaWNSNE9haUVpU3ZzcERtWlVJdGtvb25rUFg1YUlzRTNqTmRtcDN3Rlg5OUxvM3VJWGRlaWtRMHVfcTBGeWJJUFY4SW5EZ0xmLUNOLVZkV0VPdThmVXJVZ0ZYeWdDMnRlNElMYkZfWllUTVBKbE5zZzVBc1VfdGp5TTk3YkU1aEV3Q3pJZWdOMDhVRVkyc245dWs?oc=5",
    "source": "Zacks Investment Research",
    "publish_date": "Fri, 17 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Promising Potential of Viking Therapeutics\u2019 VK2735: A Buy Rating Justified by Efficacy in Weight Loss and Metabolic Health - TipRanks",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi-gFBVV95cUxNZVh6M0ducU9SUFJjUXVpZE96MlZNRFQ2d3hlREhXYWFCWXAxQ0IyeWU5NGxNbmRSdk9tTnhvQUZZbU0tVUNUSmtobmp6MGg2Zk1scXNRZWM1RFhLYjQtNVpSRnBoN0JMNkRYdEhkeXZfMGpuNU9GaW5MbDdWdTN1MXk4bmR4Y2c2X1hYX0Y5SWxhVllKQkEzZGgtZzRSc1JjVUxHSkZXNFNkX0QyeUFwb0RsNmRXaXRCZ1U5OWlIVlNpMl9CcHNZOUdOX1hULUdmUTFHTGZNaENFN2hubmhrcWE3QXFkMFFtOTJaWG9nRXZzSVZwUVBacFJB?oc=5\" target=\"_blank\">Promising Potential of Viking Therapeutics\u2019 VK2735: A Buy Rating Justified by Efficacy in Weight Loss and Metabolic Health</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
    "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxNZVh6M0ducU9SUFJjUXVpZE96MlZNRFQ2d3hlREhXYWFCWXAxQ0IyeWU5NGxNbmRSdk9tTnhvQUZZbU0tVUNUSmtobmp6MGg2Zk1scXNRZWM1RFhLYjQtNVpSRnBoN0JMNkRYdEhkeXZfMGpuNU9GaW5MbDdWdTN1MXk4bmR4Y2c2X1hYX0Y5SWxhVllKQkEzZGgtZzRSc1JjVUxHSkZXNFNkX0QyeUFwb0RsNmRXaXRCZ1U5OWlIVlNpMl9CcHNZOUdOX1hULUdmUTFHTGZNaENFN2hubmhrcWE3QXFkMFFtOTJaWG9nRXZzSVZwUVBacFJB?oc=5",
    "source": "TipRanks",
    "publish_date": "Thu, 06 Nov 2025 17:39:56 GMT"
  },
  {
    "title": "Viking Therapeutics highlights clinical data from VK2735 obesity program in presentation at ObesityWeek 2025 - MarketScreener",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPTlhlQ08xRGdrSGs3a3pGa3hULVg4dVR4R09sM19ycWw0UmtsMUM4dzczSDZ1aHFtZ3JqbTVtV1M1TGJsTTVNSGttMGh1cFlWcFBlU0gteWlxSUs3ZlJjTmlvN09xRU9LUjhraUZYZjVpZW5GZjBxSXJVMzhGcnJYVGRuRF9oaldVVkVNazBxb056OGdKZmYwUm9oR1JPaHBwVlB6VVJ5aURjMWREcXFPcE51TnNJTVJ5RVdadjZZc2xOMzVkc2kxZThUb3FEQzB5QnlwbUZxUnVBU19UOFZ3R1BwNU5LMHla?oc=5\" target=\"_blank\">Viking Therapeutics highlights clinical data from VK2735 obesity program in presentation at ObesityWeek 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>",
    "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPTlhlQ08xRGdrSGs3a3pGa3hULVg4dVR4R09sM19ycWw0UmtsMUM4dzczSDZ1aHFtZ3JqbTVtV1M1TGJsTTVNSGttMGh1cFlWcFBlU0gteWlxSUs3ZlJjTmlvN09xRU9LUjhraUZYZjVpZW5GZjBxSXJVMzhGcnJYVGRuRF9oaldVVkVNazBxb056OGdKZmYwUm9oR1JPaHBwVlB6VVJ5aURjMWREcXFPcE51TnNJTVJ5RVdadjZZc2xOMzVkc2kxZThUb3FEQzB5QnlwbUZxUnVBU19UOFZ3R1BwNU5LMHla?oc=5",
    "source": "MarketScreener",
    "publish_date": "Thu, 06 Nov 2025 12:58:47 GMT"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxOSXRWd0hEb3NGM081Vkp0SUNhSlNyYnJ1YjB0OVA1UXVsckhad1R6X1FrMVBPQ2dyemdMd3d5ekFKTUN4UjNmUkRDYVpzU0lSa0FyTkpuZHdHRmE2Ujd5aTctOFZNZzZxMDJZLWFVY2tndEEyNEJMaHJnOEpsOGdRUTMyTjVvZw?oc=5\" target=\"_blank\">The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOSXRWd0hEb3NGM081Vkp0SUNhSlNyYnJ1YjB0OVA1UXVsckhad1R6X1FrMVBPQ2dyemdMd3d5ekFKTUN4UjNmUkRDYVpzU0lSa0FyTkpuZHdHRmE2Ujd5aTctOFZNZzZxMDJZLWFVY2tndEEyNEJMaHJnOEpsOGdRUTMyTjVvZw?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Fri, 17 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics (NASDAQ: VKTX) to present VK2735 data at ObesityWeek and AHA 2025 - Stock Titan",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxOTHljdVctZjhfQXE1RkxJN3hTZHR6VFNhVS1UOHVCMFhqMlVReTlsTngtMGNqeXM0c2RlZktDVXFBc29MbHVnU1d1dE05UlFIQXZJVHAwSHVsQnFqbDRkdVFaaVMySWx1eGhaRWV4bEQycGJ0QUtxajRnWS1nbUhGX1RKQ2UxRlRIOU9vZmt5VmMtZi02cVU0TEMyRGpDbG5ZU3pxZTlDZVFIbVd4Y1ZjdnJDTDFYMnJ6V21LLTR3?oc=5\" target=\"_blank\">Viking Therapeutics (NASDAQ: VKTX) to present VK2735 data at ObesityWeek and AHA 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
    "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOTHljdVctZjhfQXE1RkxJN3hTZHR6VFNhVS1UOHVCMFhqMlVReTlsTngtMGNqeXM0c2RlZktDVXFBc29MbHVnU1d1dE05UlFIQXZJVHAwSHVsQnFqbDRkdVFaaVMySWx1eGhaRWV4bEQycGJ0QUtxajRnWS1nbUhGX1RKQ2UxRlRIOU9vZmt5VmMtZi02cVU0TEMyRGpDbG5ZU3pxZTlDZVFIbVd4Y1ZjdnJDTDFYMnJ6V21LLTR3?oc=5",
    "source": "Stock Titan",
    "publish_date": "Wed, 29 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Why Is Viking Therapeutics Stock Rising Today? - Viking Therapeutics (NASDAQ:VKTX) - Benzinga",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTi1rUzVNXzZrdXMzc3h3WEtoSTg0WGlDQ0t4d3ozOUlpdlNxUEhSOVdhemo5aWJsSGkzYU15OUNMcTIxX3ZZT1c3bklxa29KNXVGUzBXV3ZyUXdSR0hyd1Bra2xoRFI2R01jWExPWHMxM1BzU29wTnVTcHVfbWVWUy1zb2d6ekIwT2tQaV9PUzNDYzNpN3RrYWJXbFFITUt3NVZjdnRYNWdnUQ?oc=5\" target=\"_blank\">Why Is Viking Therapeutics Stock Rising Today? - Viking Therapeutics (NASDAQ:VKTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
    "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTi1rUzVNXzZrdXMzc3h3WEtoSTg0WGlDQ0t4d3ozOUlpdlNxUEhSOVdhemo5aWJsSGkzYU15OUNMcTIxX3ZZT1c3bklxa29KNXVGUzBXV3ZyUXdSR0hyd1Bra2xoRFI2R01jWExPWHMxM1BzU29wTnVTcHVfbWVWUy1zb2d6ekIwT2tQaV9PUzNDYzNpN3RrYWJXbFFITUt3NVZjdnRYNWdnUQ?oc=5",
    "source": "Benzinga",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Down 44%, Should You Buy the Dip on Viking Therapeutics? - The Motley Fool",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPYmhtQ2VqMWdDTlBrZm12MXM4ZWFMZnNWaVI3N0toUEkzQU00cHRDMHZTNlQxc1VTVVZBSXZsdFFQN05Lb2FWNFpJVXMxaG9iOUVadEJTRHpwZllld0ZFb3NzbEpULUl1NVF4UDZ3QWgzZzJGRnNVMUxXVlhGeG42MzlTeTc5TzJtellVSklJeUF2eDN0VldyZw?oc=5\" target=\"_blank\">Down 44%, Should You Buy the Dip on Viking Therapeutics?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
    "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPYmhtQ2VqMWdDTlBrZm12MXM4ZWFMZnNWaVI3N0toUEkzQU00cHRDMHZTNlQxc1VTVVZBSXZsdFFQN05Lb2FWNFpJVXMxaG9iOUVadEJTRHpwZllld0ZFb3NzbEpULUl1NVF4UDZ3QWgzZzJGRnNVMUxXVlhGeG42MzlTeTc5TzJtellVSklJeUF2eDN0VldyZw?oc=5",
    "source": "The Motley Fool",
    "publish_date": "Mon, 13 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics\u2019 VK2735 obesity program shows efficacy in new presentations - TipRanks",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPa2U3YUdHX1d5ZkJnMG9TRkxyVVBFOHZDLUFQVkZIcVVpMHZGVzdYZl9jemVEVWR2bkE5eDdaWG5yRkhhMjNITWlJZTZrZE9FZWdtc2k1TG9nNEt0WGdSNzVpM1NPTWpnZzc5LWVIc3ZJX0pwT0kxbm9EXzdQU0ttUjFqSThlMXFEY1M0TjZpZzZBSFZKdEhLak5uNHlWVndLS29lMzJTZjdVUzVRVGprMi03aU1udjQ4YUFxOWVyT1E?oc=5\" target=\"_blank\">Viking Therapeutics\u2019 VK2735 obesity program shows efficacy in new presentations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
    "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPa2U3YUdHX1d5ZkJnMG9TRkxyVVBFOHZDLUFQVkZIcVVpMHZGVzdYZl9jemVEVWR2bkE5eDdaWG5yRkhhMjNITWlJZTZrZE9FZWdtc2k1TG9nNEt0WGdSNzVpM1NPTWpnZzc5LWVIc3ZJX0pwT0kxbm9EXzdQU0ttUjFqSThlMXFEY1M0TjZpZzZBSFZKdEhLak5uNHlWVndLS29lMzJTZjdVUzVRVGprMi03aU1udjQ4YUFxOWVyT1E?oc=5",
    "source": "TipRanks",
    "publish_date": "Thu, 06 Nov 2025 13:40:27 GMT"
  },
  {
    "title": "Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? - Nasdaq",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNZndYQldkYlFIS2ZENkFiOXgwdE54VUpXbnl3QVByeVRDNVNPVEFGVkY5Z1E0cnVFRU42OWtFa19fb3Jad1Ntd3N2bHduQmVrcVhNelBIVHJ0bDFIR0ZoQmdVVGpLbzNycUFGMnZ1dnlxY0dHMkhxdGpTQU43dnJzZjIwWE9hdTdubWN4dTRSNHZlX0l3bFdZTkVzT1JRd2o1ekp1VjJ5b2tuSG95cWRTLUFXZVNYS0w4NzgzektuRQ?oc=5\" target=\"_blank\">Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZndYQldkYlFIS2ZENkFiOXgwdE54VUpXbnl3QVByeVRDNVNPVEFGVkY5Z1E0cnVFRU42OWtFa19fb3Jad1Ntd3N2bHduQmVrcVhNelBIVHJ0bDFIR0ZoQmdVVGpLbzNycUFGMnZ1dnlxY0dHMkhxdGpTQU43dnJzZjIwWE9hdTdubWN4dTRSNHZlX0l3bFdZTkVzT1JRd2o1ekp1VjJ5b2tuSG95cWRTLUFXZVNYS0w4NzgzektuRQ?oc=5",
    "source": "Nasdaq",
    "publish_date": "Fri, 17 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics, Inc. (VKTX): A Bull Case Theory - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxNMEk0N0ItS0FCUzA2a1hvV2R1djlYU1lFY1RyeU5kQjdDbUtYVlN6T2xHMDNmYWxGY3ZEWlJiSk1CVEVCN0tqaWdPM1ZYNXdsck9iaG1vR0FPTnpPZjJ0WWhERWFhalJFb1p3eVd2MUhTV3pJNFVEZFppamxvYUFxMFdtXzgtZw?oc=5\" target=\"_blank\">Viking Therapeutics, Inc. (VKTX): A Bull Case Theory</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMEk0N0ItS0FCUzA2a1hvV2R1djlYU1lFY1RyeU5kQjdDbUtYVlN6T2xHMDNmYWxGY3ZEWlJiSk1CVEVCN0tqaWdPM1ZYNXdsck9iaG1vR0FPTnpPZjJ0WWhERWFhalJFb1p3eVd2MUhTV3pJNFVEZFppamxvYUFxMFdtXzgtZw?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Tue, 16 Sep 2025 07:00:00 GMT"
  },
  {
    "title": "Why Viking Therapeutics (VKTX) Is Up 15.1% After Acquisition Buzz and Analyst Focus on Its Pipeline - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxQeEo0V3g0T25Iby05d0s5MW1wMEJsbHJXQlJFQ2xKQkYteW85RV9zQlNBOFdWUW1KNHZ0X241SEpyLWpVTGMtWHE3MUhUeTRqeVVqUXVnQ2o5M29SUFlHMXhlb2lnV0JIVzd2U2Rqb0dTT29LSzgxTVlDT2NrZm43bXQ0OA?oc=5\" target=\"_blank\">Why Viking Therapeutics (VKTX) Is Up 15.1% After Acquisition Buzz and Analyst Focus on Its Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQeEo0V3g0T25Iby05d0s5MW1wMEJsbHJXQlJFQ2xKQkYteW85RV9zQlNBOFdWUW1KNHZ0X241SEpyLWpVTGMtWHE3MUhUeTRqeVVqUXVnQ2o5M29SUFlHMXhlb2lnV0JIVzd2U2Rqb0dTT29LSzgxTVlDT2NrZm43bXQ0OA?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Mon, 06 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics: Overdue For Gains (NASDAQ:VKTX) - Seeking Alpha",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxQdG4tZEs4M2pQZlctZWNmMHphOEVyTmlodm9XYjdVYzZMckkyWUFoM1dzNkJMcFRQUkFRX0ZFN3pNenNVQmN4ejJPYzgtWmJSVl9FYndiUjVGeTB5eXozWHo5UlhVdmFTcnQtdnNfSUk3dnVMQjV1M092b2dQZkFxZUI4S2Y?oc=5\" target=\"_blank\">Viking Therapeutics: Overdue For Gains (NASDAQ:VKTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQdG4tZEs4M2pQZlctZWNmMHphOEVyTmlodm9XYjdVYzZMckkyWUFoM1dzNkJMcFRQUkFRX0ZFN3pNenNVQmN4ejJPYzgtWmJSVl9FYndiUjVGeTB5eXozWHo5UlhVdmFTcnQtdnNfSUk3dnVMQjV1M092b2dQZkFxZUI4S2Y?oc=5",
    "source": "Seeking Alpha",
    "publish_date": "Sun, 28 Sep 2025 07:00:00 GMT"
  },
  {
    "title": "Why Shares in Viking Therapeutics Surged This Week - The Motley Fool",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxQMkYzUmhOZFN0RktudkVPa040ejBJOGJyeXFzMHBWVVA5N2hxY0diNjNVWE1fRE5oc3dfREFWUWM4Y09KZTV6dUJwUUJBVEpGMEFPMkY4MFFiRUdjUEJHQ2Y3aWdEUzJ4NjlfcDVlbG12a2pEN1dqSHp0cEVvanBwRThqb0gxNTZzdzhBV3BKQ1AtX0hMVEdlbA?oc=5\" target=\"_blank\">Why Shares in Viking Therapeutics Surged This Week</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
    "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQMkYzUmhOZFN0RktudkVPa040ejBJOGJyeXFzMHBWVVA5N2hxY0diNjNVWE1fRE5oc3dfREFWUWM4Y09KZTV6dUJwUUJBVEpGMEFPMkY4MFFiRUdjUEJHQ2Y3aWdEUzJ4NjlfcDVlbG12a2pEN1dqSHp0cEVvanBwRThqb0gxNTZzdzhBV3BKQ1AtX0hMVEdlbA?oc=5",
    "source": "The Motley Fool",
    "publish_date": "Thu, 09 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Can Viking Therapeutics Inc. stock reach $100 price target - Quarterly Portfolio Report & Consistent Profit Trading Strategies - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxQdDA3LURTS3hiNnZrWHNkd2tqOUJrSGNCVERobmxQUlpfYzl2RlJSNFhYZXZIVjJxRXNwbVloTEJuUURnYkJvVUpZS0Y4RmlHLURDNlFhSVFkaktOeHFsb3ZGNnlaZThmMnVBbWZMNzM0cFJaaS0wWWFIbWhEMzVDVWdNNlZwWkxiaTVvWmx4OWNiS25DR2c0TWVn?oc=5\" target=\"_blank\">Can Viking Therapeutics Inc. stock reach $100 price target - Quarterly Portfolio Report & Consistent Profit Trading Strategies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQdDA3LURTS3hiNnZrWHNkd2tqOUJrSGNCVERobmxQUlpfYzl2RlJSNFhYZXZIVjJxRXNwbVloTEJuUURnYkJvVUpZS0Y4RmlHLURDNlFhSVFkaktOeHFsb3ZGNnlaZThmMnVBbWZMNzM0cFJaaS0wWWFIbWhEMzVDVWdNNlZwWkxiaTVvWmx4OWNiS25DR2c0TWVn?oc=5",
    "source": "newser.com",
    "publish_date": "Fri, 07 Nov 2025 07:18:58 GMT"
  },
  {
    "title": "Druckenmiller's Viking Trade Just Hit A Golden Cross \u2014 And A Sweet 36% Gain - Benzinga",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPZG1La2tEaWlQVjM1UzJEMHVMUmk0STc1bWtSZTRuczJnc0xjME45Mm9wOERrNkEydGJuSnlVYko5aDBJRDA1Qkg1TXJXd054Y081MTl3akxYenpJd1J3dDI4NU9WYXhaSk1MWkJBckRQb2ZUNjI4S3BiWE42MWxyTEtQS3RpUDBUVG1EYzBZNDl2T3B1UHpkdXVfc0xnWXYzVUpnVGk4b0RPRWYwZ3ptSmN6VUtmSGpFWnVkbEJTaVNXYTk4QW9DVzZ1Z2dIOU85Z3c?oc=5\" target=\"_blank\">Druckenmiller's Viking Trade Just Hit A Golden Cross \u2014 And A Sweet 36% Gain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
    "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPZG1La2tEaWlQVjM1UzJEMHVMUmk0STc1bWtSZTRuczJnc0xjME45Mm9wOERrNkEydGJuSnlVYko5aDBJRDA1Qkg1TXJXd054Y081MTl3akxYenpJd1J3dDI4NU9WYXhaSk1MWkJBckRQb2ZUNjI4S3BiWE42MWxyTEtQS3RpUDBUVG1EYzBZNDl2T3B1UHpkdXVfc0xnWXYzVUpnVGk4b0RPRWYwZ3ptSmN6VUtmSGpFWnVkbEJTaVNXYTk4QW9DVzZ1Z2dIOU85Z3c?oc=5",
    "source": "Benzinga",
    "publish_date": "Wed, 05 Nov 2025 15:01:24 GMT"
  },
  {
    "title": "Viking Therapeutics\u2019 VK2735: A Promising Phase 3 Study for Weight Management - TipRanks",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMixAFBVV95cUxOLXExakQ1b19sUEFfMmtzM2tiSUh5WVhoSmwwUnY1alVUVVdZOGFaVUhobUpPSndzRHVsMWRlY2JpcjZlbHlhMXFGajNUSTB1MUUwalZDXy1TQlVDYnNvUVRJSUdKZ242VXN3MkhTWEZENTNxdG9OckJUWkxmamo4b3NHekw3WG5zUG9fZkRMc3ZhbUZHUVNSaTBHcmd0WTgyTXFGMUpxTURoS3NHa3FlX1pMc0lJaXlYcUJHVjBOOGxpMjlp?oc=5\" target=\"_blank\">Viking Therapeutics\u2019 VK2735: A Promising Phase 3 Study for Weight Management</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
    "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOLXExakQ1b19sUEFfMmtzM2tiSUh5WVhoSmwwUnY1alVUVVdZOGFaVUhobUpPSndzRHVsMWRlY2JpcjZlbHlhMXFGajNUSTB1MUUwalZDXy1TQlVDYnNvUVRJSUdKZ242VXN3MkhTWEZENTNxdG9OckJUWkxmamo4b3NHekw3WG5zUG9fZkRMc3ZhbUZHUVNSaTBHcmd0WTgyTXFGMUpxTURoS3NHa3FlX1pMc0lJaXlYcUJHVjBOOGxpMjlp?oc=5",
    "source": "TipRanks",
    "publish_date": "Mon, 27 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics Navigates Regulatory Risks Amid U.S. Policy Shifts - TipRanks",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxOX05VTDljZDdBV19ZTW1CRDJKUUowYUd6UVI0SXVoanBBdUM4ZGF2MXI5Q2tJY0dBQnoybVM4RzEyeXBZYW1lYnNGbEgzal9Zd1Rwc01KOWJhSnNpMmtCZFNfdDRSTDZSYmFsaVZ5NWlYZWljZ2tsNzRiSDZBODN4NXk3UmkzU0NGMjRZaWx2NEI5Q2xaa0Nrci1XcjVkMXc4aUIyZC1EdzRxVllTWFJrYS1fX19XbUU0OS1hSWx3?oc=5\" target=\"_blank\">Viking Therapeutics Navigates Regulatory Risks Amid U.S. Policy Shifts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
    "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOX05VTDljZDdBV19ZTW1CRDJKUUowYUd6UVI0SXVoanBBdUM4ZGF2MXI5Q2tJY0dBQnoybVM4RzEyeXBZYW1lYnNGbEgzal9Zd1Rwc01KOWJhSnNpMmtCZFNfdDRSTDZSYmFsaVZ5NWlYZWljZ2tsNzRiSDZBODN4NXk3UmkzU0NGMjRZaWx2NEI5Q2xaa0Nrci1XcjVkMXc4aUIyZC1EdzRxVllTWFJrYS1fX19XbUU0OS1hSWx3?oc=5",
    "source": "TipRanks",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics (VKTX): Assessing Valuation as VK2735 Clinical Updates Fuel Investor Interest - simplywall.st",
    "content": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Viking Therapeutics (VKTX): Assessing Valuation as VK2735 Clinical Updates Fuel Investor Interest</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
    "url": "https://news.google.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?oc=5",
    "source": "simplywall.st",
    "publish_date": "Fri, 31 Oct 2025 19:49:50 GMT"
  },
  {
    "title": "Earnings call transcript: Viking Therapeutics Q2 2025 sees increased R&D expenses - Investing.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPMTdVMHRzVW9iYVZHY29TMDBTcUExemNBVVBhWFZIRkFWX1ctekpMeWhyREpCLVlRUkNxUG9uNEpZSlQ5RGhKemdTdlNnUVJldWlVNUtuU2ZXMmMySlRYM3NWMGh1Tlpoc0pRdUZDM3dJOE41eE8zTjAtaU13dWV3T2NwdHhkVEk2WHdEYml1djk2VUtHa2VhVGU1eUhWNWlmNDRVRmxwNFVEeGd4dWVFLTF3QzdzNHlkcmZSblZ1Y2tXZHhPRXhudUhwWWp3TWMy?oc=5\" target=\"_blank\">Earnings call transcript: Viking Therapeutics Q2 2025 sees increased R&amp;D expenses</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
    "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPMTdVMHRzVW9iYVZHY29TMDBTcUExemNBVVBhWFZIRkFWX1ctekpMeWhyREpCLVlRUkNxUG9uNEpZSlQ5RGhKemdTdlNnUVJldWlVNUtuU2ZXMmMySlRYM3NWMGh1Tlpoc0pRdUZDM3dJOE41eE8zTjAtaU13dWV3T2NwdHhkVEk2WHdEYml1djk2VUtHa2VhVGU1eUhWNWlmNDRVRmxwNFVEeGd4dWVFLTF3QzdzNHlkcmZSblZ1Y2tXZHhPRXhudUhwWWp3TWMy?oc=5",
    "source": "Investing.com",
    "publish_date": "Tue, 14 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Canaccord Genuity Initiates Coverage of Viking Therapeutics (VKTX) with Buy Recommendation - Nasdaq",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxOSVgxUng0Y2FHMVZGdmZwaGY0OWJua3d2ZGZpUlg3MUNxXzFhSWwyZWNqM01YVmFlejVaRXBnUVZ5QWNLZUdEREdRbVRiZmhzR056OUs5MEFDWnAzcmFJYkg2eHBDaFd4SG9pakFBb1pCWi1OeXBjOG1iU0NTNUxUa3loQjdvTFN0Q21GNjBHLW5iVncwUGtpa0tOVTVjTExBa0lvWTllUFh6X3o0N0NfM0dn?oc=5\" target=\"_blank\">Canaccord Genuity Initiates Coverage of Viking Therapeutics (VKTX) with Buy Recommendation</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOSVgxUng0Y2FHMVZGdmZwaGY0OWJua3d2ZGZpUlg3MUNxXzFhSWwyZWNqM01YVmFlejVaRXBnUVZ5QWNLZUdEREdRbVRiZmhzR056OUs5MEFDWnAzcmFJYkg2eHBDaFd4SG9pakFBb1pCWi1OeXBjOG1iU0NTNUxUa3loQjdvTFN0Q21GNjBHLW5iVncwUGtpa0tOVTVjTExBa0lvWTllUFh6X3o0N0NfM0dn?oc=5",
    "source": "Nasdaq",
    "publish_date": "Wed, 29 Oct 2025 12:03:00 GMT"
  },
  {
    "title": "Can Viking Therapeutics (VKTX) Sustain Its Innovation Edge in Obesity Treatments Amid Intensifying Competition? - simplywall.st",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOS3dXa3d6Y1Rzdkg3MDFZYlMyVHJ5dmxpQWxKWWNzSEZxRmNqajNEOGJ2NEc2ek9OYWhndXFWX0hOU1A5dXZVczFoRVNuZ1V2eFg5MTlzX21LYm1wTzZZTDBETG1zOUFDVURCY2FDT0ZLSFlhTFJEYm55WWJqR3hDbHZ1UGZDYnFRMnJzYTR0TEpkU05sakFkaWNYdlZlSUxkRWdNSU5MWjQxaTRESFBuUkJQRERIR0p3bkVoZnB5TWNuT0VXdVBwZE1FZmgyZXlrUmp2OFJ2NGozdzJ6UmZVYi1PNTQ2c1XSAewBQVVfeXFMTjZfUmU3Y09paDN2emptSkp2b3BtRjZQRGxaeUVCcko5T2lxTkJCUVFkbVF5OXRSQ2JYZ2gxS2dILWNVQkJsY1JUWWlHajY4SUFZZU1kcklObDlrTlY0VF9KRDluSndJaE9Db01HWUluS1hhaGU1RkZOWmVENS1zTThUTEcwWERlaC15b1ZWV1ZuVEJtbmxYekp1SlFXczFuLWxLRjFCNnJ4aDFiT001NDhSd3lEeWRrVFYyMUhQRHNGZTNpeE14MGJzU2c5eHhFMTVWSHVrS2lQeUNaZlpUbGQ0UWFFTGRycS0wTzc?oc=5\" target=\"_blank\">Can Viking Therapeutics (VKTX) Sustain Its Innovation Edge in Obesity Treatments Amid Intensifying Competition?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
    "url": "https://news.google.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?oc=5",
    "source": "simplywall.st",
    "publish_date": "Wed, 29 Oct 2025 23:01:43 GMT"
  },
  {
    "title": "MASH, Metsera Deals Send Analysts Marauding to Viking - BioSpace",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxNLURCTV9iWVFpNmlOd2JvUWF0SndIQS1GZGZ6dmw3TVp6RFhYemdDczVrbnhLRzB2RVFwQnY2RHlMeUt1YTE1azEwRmNwOGxhSm50UXJSTTRnM2xJMG1sRTFVeWNHa0Q2UjBTWUNlNFcwMWFBRFR1NTlqRnN4cnBpOGo5S3pZeE9YNDk4eDB2NA?oc=5\" target=\"_blank\">MASH, Metsera Deals Send Analysts Marauding to Viking</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
    "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNLURCTV9iWVFpNmlOd2JvUWF0SndIQS1GZGZ6dmw3TVp6RFhYemdDczVrbnhLRzB2RVFwQnY2RHlMeUt1YTE1azEwRmNwOGxhSm50UXJSTTRnM2xJMG1sRTFVeWNHa0Q2UjBTWUNlNFcwMWFBRFR1NTlqRnN4cnBpOGo5S3pZeE9YNDk4eDB2NA?oc=5",
    "source": "BioSpace",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Can Viking Therapeutics Hold Its Edge as Obesity Rivalry Heats Up? - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOZlA1ZHlJVE9VRE1Idkc0S0xOdVNLR0hTRDFXWlNDbERoLVYzVVU2OS1mUG9TQUc2QkRHSkJXeWFLdU5CYzZTalA3TDdkZWttR2dvaHlTYkhZOHhKamd1NEVHblI2NkQtb3hnZ1VxZ1F1MXVyOVFKN0txdzk3ZlFlRUFaejFvWjFkdGVr?oc=5\" target=\"_blank\">Can Viking Therapeutics Hold Its Edge as Obesity Rivalry Heats Up?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOZlA1ZHlJVE9VRE1Idkc0S0xOdVNLR0hTRDFXWlNDbERoLVYzVVU2OS1mUG9TQUc2QkRHSkJXeWFLdU5CYzZTalA3TDdkZWttR2dvaHlTYkhZOHhKamd1NEVHblI2NkQtb3hnZ1VxZ1F1MXVyOVFKN0txdzk3ZlFlRUFaejFvWjFkdGVr?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Thu, 25 Sep 2025 07:00:00 GMT"
  },
  {
    "title": "Can Viking Therapeutics Inc. (1VT) stock sustain margin levels - Market Risk Analysis & Free Low Drawdown Momentum Trade Ideas - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxNdTB3YVEycGVsRHpia3cxMGZqRm5fdnN4Z0VYRE9VU0R5M0dOVmxuZzF5Zjh3TmszaDJOdkZPcVdEb0VhRTFJcERld2VSdjlNOVlUVlcyTFJHQ01PeWp1N1lfOHJYWTdMS2Y3ZVVibFdDVU0yRi1SVl9oUURuZ0dNQUphUEtZOUJGeW04YWU2ZXNMQ09yZG05ZGV3cHQxQQ?oc=5\" target=\"_blank\">Can Viking Therapeutics Inc. (1VT) stock sustain margin levels - Market Risk Analysis & Free Low Drawdown Momentum Trade Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdTB3YVEycGVsRHpia3cxMGZqRm5fdnN4Z0VYRE9VU0R5M0dOVmxuZzF5Zjh3TmszaDJOdkZPcVdEb0VhRTFJcERld2VSdjlNOVlUVlcyTFJHQ01PeWp1N1lfOHJYWTdMS2Y3ZVVibFdDVU0yRi1SVl9oUURuZ0dNQUphUEtZOUJGeW04YWU2ZXNMQ09yZG05ZGV3cHQxQQ?oc=5",
    "source": "newser.com",
    "publish_date": "Tue, 04 Nov 2025 00:32:46 GMT"
  },
  {
    "title": "BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PT - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxPWkJ0YWJmMVc0SURLWWpVWHJ2ZTdHZHBMc3I0bllBVkM2d0p6blp2cUt0cmlraGdVUU8zcFRISXZOeWozMWpaeThYeTV5T29XTExlVXhLT0tLeVRUU05jUEFKVjNwenJQXzhzVWRpRlJCT0xuenBPT25BWGlENHlQNTFtUmRfQQ?oc=5\" target=\"_blank\">BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PT</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPWkJ0YWJmMVc0SURLWWpVWHJ2ZTdHZHBMc3I0bllBVkM2d0p6blp2cUt0cmlraGdVUU8zcFRISXZOeWozMWpaeThYeTV5T29XTExlVXhLT0tLeVRUU05jUEFKVjNwenJQXzhzVWRpRlJCT0xuenBPT25BWGlENHlQNTFtUmRfQQ?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Tue, 30 Sep 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxOQXZTZ3JxOGdpX2phWTMwMnNZM21GQnhUVno4U29KMU82SlQzNXI0alByLWVzYkRVd29WLUFrSl9uX2tPNTEyR1V3cUF1bFpNVnlZcW8yX1g4T1YwelJ6T0JPajNtc0p5WDR2ek15TFNYT29uR0ltTnZ5TGxVcmNDaFVHU2lQeEE?oc=5\" target=\"_blank\">Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOQXZTZ3JxOGdpX2phWTMwMnNZM21GQnhUVno4U29KMU82SlQzNXI0alByLWVzYkRVd29WLUFrSl9uX2tPNTEyR1V3cUF1bFpNVnlZcW8yX1g4T1YwelJ6T0JPajNtc0p5WDR2ek15TFNYT29uR0ltTnZ5TGxVcmNDaFVHU2lQeEE?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Thu, 02 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics: A High-Stakes Biotech Bet - AD HOC NEWS",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxPYXlWcGlpYnZDS05sbGsydFAydWNrWmlwM2Z6OTFKczdwVzNjRFdwQjB1MmprYTFuc2J2eUwzeGduU2lCdDJrMHAwMHpRaGhFaXRoUjl0RTduUTlXUW1NakVjVHY3Q1NFUmRlSlJvYUZId1kyRElRUUxrRzlFZ2JuTGtYRXBCNnZXV0hvNXloRUtocUxyR2JzR3BjcDlJYWkz?oc=5\" target=\"_blank\">Viking Therapeutics: A High-Stakes Biotech Bet</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AD HOC NEWS</font>",
    "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPYXlWcGlpYnZDS05sbGsydFAydWNrWmlwM2Z6OTFKczdwVzNjRFdwQjB1MmprYTFuc2J2eUwzeGduU2lCdDJrMHAwMHpRaGhFaXRoUjl0RTduUTlXUW1NakVjVHY3Q1NFUmRlSlJvYUZId1kyRElRUUxrRzlFZ2JuTGtYRXBCNnZXV0hvNXloRUtocUxyR2JzR3BjcDlJYWkz?oc=5",
    "source": "AD HOC NEWS",
    "publish_date": "Sun, 09 Nov 2025 04:09:04 GMT"
  },
  {
    "title": "Viking Therapeutics (VKTX): Assessing Valuation as VK2735 Clinical Updates Fuel Investor Interest - Sahm",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMi3wFBVV95cUxObTlSaThEa3RwMW1IS3FJOEFjbS1qRjVuMzQyVTZnTF95dXRDTnEtMUU1cjNmRDMyRm1IWEpxVVQta0RyTXdFNU1JeUJuVGswSlBZZFhZZ3dhY0JrdEl5UjlzUzVVT3ZIVWpkLThvTHNTTDhSNFgyTm1yMmgwTDNJTGU4LUE0RDVJeTNKaXRwc0JyMXRwQWxIQWFockZnMDF6dDAzMjZWd3NkRFJBSFhKeHdEMTJTSnkxRXhUY2tLTjIwVUQ1WHdBd19RdDNIb2RpZVY3a1Uwb2hZR2wtb2dJ?oc=5\" target=\"_blank\">Viking Therapeutics (VKTX): Assessing Valuation as VK2735 Clinical Updates Fuel Investor Interest</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Sahm</font>",
    "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxObTlSaThEa3RwMW1IS3FJOEFjbS1qRjVuMzQyVTZnTF95dXRDTnEtMUU1cjNmRDMyRm1IWEpxVVQta0RyTXdFNU1JeUJuVGswSlBZZFhZZ3dhY0JrdEl5UjlzUzVVT3ZIVWpkLThvTHNTTDhSNFgyTm1yMmgwTDNJTGU4LUE0RDVJeTNKaXRwc0JyMXRwQWxIQWFockZnMDF6dDAzMjZWd3NkRFJBSFhKeHdEMTJTSnkxRXhUY2tLTjIwVUQ1WHdBd19RdDNIb2RpZVY3a1Uwb2hZR2wtb2dJ?oc=5",
    "source": "Sahm",
    "publish_date": "Fri, 31 Oct 2025 19:41:15 GMT"
  },
  {
    "title": "Viking Therapeutics Stock: A Watershed Moment in Obesity Treatment? - AD HOC NEWS",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNLWIxdXREV0xnT3RuWU5pVlJ5eFBKbFEzM0xsVlZfU1Z1VWZEYlQwM2lfVV9RSnhRanFBcEVJLWM4SEJQRjZiOE42dWY3eEY3Z2NiWE1pN1FxU1dJNV9hME1LN2xsbkVJaTRVS0JPRHZnb2FheXBqVDBTcnpIdThWb3RpZGpiZVBUVW00M3haZkRWaldlUnVKb2xIVFRIWUt2QkRqWmE0emw2WFNTUmgzU29sdzNYOXlfTVk0?oc=5\" target=\"_blank\">Viking Therapeutics Stock: A Watershed Moment in Obesity Treatment?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AD HOC NEWS</font>",
    "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNLWIxdXREV0xnT3RuWU5pVlJ5eFBKbFEzM0xsVlZfU1Z1VWZEYlQwM2lfVV9RSnhRanFBcEVJLWM4SEJQRjZiOE42dWY3eEY3Z2NiWE1pN1FxU1dJNV9hME1LN2xsbkVJaTRVS0JPRHZnb2FheXBqVDBTcnpIdThWb3RpZGpiZVBUVW00M3haZkRWaldlUnVKb2xIVFRIWUt2QkRqWmE0emw2WFNTUmgzU29sdzNYOXlfTVk0?oc=5",
    "source": "AD HOC NEWS",
    "publish_date": "Wed, 05 Nov 2025 09:10:04 GMT"
  },
  {
    "title": "Viking Therapeutics Advances Obesity Treatment Pipeline - TipRanks",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPeHRJakJCSXYxeUtFbFBBcW9oLUhCZnRkTzl2UW1NdWdZTGZkdlFSbDFNVXNycXVyLXFja2w0MUhRTXAxRFVsYVdRdHMwamxoRFU3NzBpNm1QME1VTE5ZT1N3dmg5a0QxQU1PVXliQW5ObGk2MGYyajdBMmVEd2ZlRHJBT0VrWFZMVmNwRmp0X3lsN0FFdmpGQ2pHTjlKSGZqTk1sekZMd0N3dDQ?oc=5\" target=\"_blank\">Viking Therapeutics Advances Obesity Treatment Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
    "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPeHRJakJCSXYxeUtFbFBBcW9oLUhCZnRkTzl2UW1NdWdZTGZkdlFSbDFNVXNycXVyLXFja2w0MUhRTXAxRFVsYVdRdHMwamxoRFU3NzBpNm1QME1VTE5ZT1N3dmg5a0QxQU1PVXliQW5ObGk2MGYyajdBMmVEd2ZlRHJBT0VrWFZMVmNwRmp0X3lsN0FFdmpGQ2pHTjlKSGZqTk1sekZMd0N3dDQ?oc=5",
    "source": "TipRanks",
    "publish_date": "Wed, 22 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMizAFBVV95cUxNdUR5dkxaWjhUUnZodVUxOWpRa09NMC00ZWVNZGNFZmxpX2RJaTBMMEpVYk5KT25ERC1YNTZtZXg2QUZpeGxaSGp5WWVROGNkMjRGYTE1bzYwQjl1bWhRZ29XVGVBeG9JV0J1cFFOR0l5ZVNiaHhDNFd4ZFBfVjdOM2ZFR0ozS2tmN2dRN2Y1Yk5Bc0hVY3hHTkp6eThEN3JPZ3FuS3g0dGdEdVhQc0t4R0t2c2hiZjlXVlJGbmJyUkJGeDQ2dmlCR0dHNzI?oc=5\" target=\"_blank\">Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNdUR5dkxaWjhUUnZodVUxOWpRa09NMC00ZWVNZGNFZmxpX2RJaTBMMEpVYk5KT25ERC1YNTZtZXg2QUZpeGxaSGp5WWVROGNkMjRGYTE1bzYwQjl1bWhRZ29XVGVBeG9JV0J1cFFOR0l5ZVNiaHhDNFd4ZFBfVjdOM2ZFR0ozS2tmN2dRN2Y1Yk5Bc0hVY3hHTkp6eThEN3JPZ3FuS3g0dGdEdVhQc0t4R0t2c2hiZjlXVlJGbmJyUkJGeDQ2dmlCR0dHNzI?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Tue, 19 Aug 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics: High Risk, High Reward Play - The Globe and Mail",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMizAFBVV95cUxQYkhwOGV0MW9peF9KcjNXR3NBRFBOdjRrbGtYT3g5VVJkXzF2SmM1cWNNY0RJdzVBc1ZmbmdJbXBFTnNiaDNJVzBuSFllMXVjWGk1Q1RIMFdOX3NLX01TNXI2OG5pNVlST2k2Q1lFVWtuWGNoSmxMTWdfRkxBNF9pU2cyQ3JLazRBUnlpQ0JncEwxUERhaVFsMllTLTlZMGhiVm82SjU4TUVHNXRMTWFWcjgyYUFMd1paZDJnaUdBSDlaVTlORXNTR1kxTHU?oc=5\" target=\"_blank\">Viking Therapeutics: High Risk, High Reward Play</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
    "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYkhwOGV0MW9peF9KcjNXR3NBRFBOdjRrbGtYT3g5VVJkXzF2SmM1cWNNY0RJdzVBc1ZmbmdJbXBFTnNiaDNJVzBuSFllMXVjWGk1Q1RIMFdOX3NLX01TNXI2OG5pNVlST2k2Q1lFVWtuWGNoSmxMTWdfRkxBNF9pU2cyQ3JLazRBUnlpQ0JncEwxUERhaVFsMllTLTlZMGhiVm82SjU4TUVHNXRMTWFWcjgyYUFMd1paZDJnaUdBSDlaVTlORXNTR1kxTHU?oc=5",
    "source": "The Globe and Mail",
    "publish_date": "Mon, 27 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "How Viking Therapeutics Inc. (1VT) stock reacts to stronger dollar - Quarterly Earnings Report & Reliable Volume Spike Trade Alerts - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxONEV3YS0td1NHZ1gzejhhd3ByTTBwNXl1eklpMGFoMmNkU2RJR29xbWxHZ3BraDdNazROTGttYVRZNnVlYjgxVmYxSU9MbWUyU2VzYkE5TV9UZEw1RXdHQl9iYnUxSzN5WUc3RU4yT2NwM3RPTEw5Z2s2N1EyNnYwbDdIeFNUa3dlaDVzTDlvVlNveXpoblEzTVdOUERrSGpBT0E5Mw?oc=5\" target=\"_blank\">How Viking Therapeutics Inc. (1VT) stock reacts to stronger dollar - Quarterly Earnings Report & Reliable Volume Spike Trade Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxONEV3YS0td1NHZ1gzejhhd3ByTTBwNXl1eklpMGFoMmNkU2RJR29xbWxHZ3BraDdNazROTGttYVRZNnVlYjgxVmYxSU9MbWUyU2VzYkE5TV9UZEw1RXdHQl9iYnUxSzN5WUc3RU4yT2NwM3RPTEw5Z2s2N1EyNnYwbDdIeFNUa3dlaDVzTDlvVlNveXpoblEzTVdOUERrSGpBT0E5Mw?oc=5",
    "source": "newser.com",
    "publish_date": "Wed, 05 Nov 2025 15:54:30 GMT"
  },
  {
    "title": "How Viking Therapeutics Inc. (1VT) stock reacts to stronger dollar - 2025 Key Highlights & Precise Buy Zone Tips - newser.com",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPQVgydEV3cndqbWt5dFgyd1I4S0NWX1ZPSHJjcnFXeExDelczRDhlMmRISkJoZ2t4RzBqZWxnNV9Fc0JNcjNCajVzSzZRWkUyRmZPbGhrWk10eWY1U1NJUlZRaG03YmcxUlg4WVZac2ZHdEpWN0V1ODNaVFgwU292Qm03YzJIN2o0NFVnazh5dVVNWUdJSVVSTUdobmg1bUp1WlJR?oc=5\" target=\"_blank\">How Viking Therapeutics Inc. (1VT) stock reacts to stronger dollar - 2025 Key Highlights & Precise Buy Zone Tips</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
    "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPQVgydEV3cndqbWt5dFgyd1I4S0NWX1ZPSHJjcnFXeExDelczRDhlMmRISkJoZ2t4RzBqZWxnNV9Fc0JNcjNCajVzSzZRWkUyRmZPbGhrWk10eWY1U1NJUlZRaG03YmcxUlg4WVZac2ZHdEpWN0V1ODNaVFgwU292Qm03YzJIN2o0NFVnazh5dVVNWUdJSVVSTUdobmg1bUp1WlJR?oc=5",
    "source": "newser.com",
    "publish_date": "Thu, 06 Nov 2025 18:38:39 GMT"
  },
  {
    "title": "Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months - The Motley Fool",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxQZ2Z0SjVIZzc5Snhqd2xQdUh3dm9Nay05ZmI5eUdYX09fVlJnS3lfV09YV0VYeUlUZXdRcTR5RVc3dUNEalhFVWVQTnAtTDlKZzQ1Z1UyVEVncHFCYmxQcm02bjNvTWdTMFBPLUt0N0dPU1FyZ1p5VWhYdTNobVY3OG93YjlEMzgwLWZXNVduSWtwQkk?oc=5\" target=\"_blank\">Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
    "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQZ2Z0SjVIZzc5Snhqd2xQdUh3dm9Nay05ZmI5eUdYX09fVlJnS3lfV09YV0VYeUlUZXdRcTR5RVc3dUNEalhFVWVQTnAtTDlKZzQ1Z1UyVEVncHFCYmxQcm02bjNvTWdTMFBPLUt0N0dPU1FyZ1p5VWhYdTNobVY3OG93YjlEMzgwLWZXNVduSWtwQkk?oc=5",
    "source": "The Motley Fool",
    "publish_date": "Fri, 19 Sep 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics Stock: A Speculative Buy (NASDAQ:VKTX) - Seeking Alpha",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxPQjhSQ0NsMlptc1FLU241Mk5tUGpfTWN1RldQY0JYdUp1X19TaEJiUjJpQWtwbnRFNy0ycldXb0JSMnR2MzR1ZmNlYU80YlRpQUNSeDhGeUp0TWtmdm9Lbi1Lbi1qMHQ2T1l5YUQ4MEJSd2dLOHlJWUl1S3hQS0VFTXo3R0k?oc=5\" target=\"_blank\">Viking Therapeutics Stock: A Speculative Buy (NASDAQ:VKTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPQjhSQ0NsMlptc1FLU241Mk5tUGpfTWN1RldQY0JYdUp1X19TaEJiUjJpQWtwbnRFNy0ycldXb0JSMnR2MzR1ZmNlYU80YlRpQUNSeDhGeUp0TWtmdm9Lbi1Lbi1qMHQ2T1l5YUQ4MEJSd2dLOHlJWUl1S3hQS0VFTXo3R0k?oc=5",
    "source": "Seeking Alpha",
    "publish_date": "Sat, 04 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxOZmRMaWNiMkdqOG5XeXZiUzdIbHBtczYzZ3FCNXdjelhnb3BlU280VTlvWUVfaDd6djRZZzAwZmJYbm91UzQ5OXg1LWxPMU1DZGhibmJmemN2Y29oc3FGc0QtdHhvT2RhdnVwMmIwQnFHMjVvTEJKSXlGYU5Vdklady1wTWEzQ1k?oc=5\" target=\"_blank\">Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOZmRMaWNiMkdqOG5XeXZiUzdIbHBtczYzZ3FCNXdjelhnb3BlU280VTlvWUVfaDd6djRZZzAwZmJYbm91UzQ5OXg1LWxPMU1DZGhibmJmemN2Y29oc3FGc0QtdHhvT2RhdnVwMmIwQnFHMjVvTEJKSXlGYU5Vdklady1wTWEzQ1k?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Mon, 15 Sep 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics Stock Powers Toward Best Month Of The Year \u2014 Wall Street, Retail Bulls Fired Up On Obesity Drug Promise - MSN",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiggJBVV95cUxORWtLbkttQUdST05oLTIzZzRlZWVIU003c1d1UjltXzJIUTFQX0Z5aGp1bHBDQ3pvM1JINnRQR3hCRnc1R01fN2xzU0lpMktqcHgyTWQ2ZGVodWZ6aWRLQy1JUWs5d0RiSGJoOXZ2TTdGN3dLa2pzcEhjaERFNWNLUTlZNzdrc0hLZmgzelpfemVxazJvUVcyMjlSMGQ0WXZWWXBNVVRzdUI4N0pvNkFNQkRoSG9sOUNBOEVxX0pZdzQyZ2h2aHZMcGI3RXNHMzdSZGE1RHYxQlVWVXN3UDFmdUNSMnhVMWN5Q01ncno0NEFJNndsQjFxYUZ5WUI0a3BDVHc?oc=5\" target=\"_blank\">Viking Therapeutics Stock Powers Toward Best Month Of The Year \u2014 Wall Street, Retail Bulls Fired Up On Obesity Drug Promise</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
    "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxORWtLbkttQUdST05oLTIzZzRlZWVIU003c1d1UjltXzJIUTFQX0Z5aGp1bHBDQ3pvM1JINnRQR3hCRnc1R01fN2xzU0lpMktqcHgyTWQ2ZGVodWZ6aWRLQy1JUWs5d0RiSGJoOXZ2TTdGN3dLa2pzcEhjaERFNWNLUTlZNzdrc0hLZmgzelpfemVxazJvUVcyMjlSMGQ0WXZWWXBNVVRzdUI4N0pvNkFNQkRoSG9sOUNBOEVxX0pZdzQyZ2h2aHZMcGI3RXNHMzdSZGE1RHYxQlVWVXN3UDFmdUNSMnhVMWN5Q01ncno0NEFJNndsQjFxYUZ5WUI0a3BDVHc?oc=5",
    "source": "MSN",
    "publish_date": "Fri, 31 Oct 2025 07:51:36 GMT"
  },
  {
    "title": "Viking Therapeutics\u2019 Earnings Call: Clinical Success Amid Financial Challenges - TipRanks",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxPc0o4eWgxVGU4Uy1vYnYxck9RZm05Q0pXZUd0UFhucVRncmR5cEctRzJoMG9qS3plbFB4eFpSTUJYSGIzd0QtM205T3Z6MTM0MlFZS1lLSzNyUXJVLVc2eThVQUFjeXZlTzRxcHMxMlNoTGp6S0VqZ1hfNlFvWk9lVXR3TTh6UXNGNDMxS3Z3MFh4YzV4akNjekJubnhyRjItczBxUEhIcFpuRXk5SjNZZDV6dGhEMkZYcnNkN2V0N0xlMERUOEI0?oc=5\" target=\"_blank\">Viking Therapeutics\u2019 Earnings Call: Clinical Success Amid Financial Challenges</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
    "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPc0o4eWgxVGU4Uy1vYnYxck9RZm05Q0pXZUd0UFhucVRncmR5cEctRzJoMG9qS3plbFB4eFpSTUJYSGIzd0QtM205T3Z6MTM0MlFZS1lLSzNyUXJVLVc2eThVQUFjeXZlTzRxcHMxMlNoTGp6S0VqZ1hfNlFvWk9lVXR3TTh6UXNGNDMxS3Z3MFh4YzV4akNjekJubnhyRjItczBxUEhIcFpuRXk5SjNZZDV6dGhEMkZYcnNkN2V0N0xlMERUOEI0?oc=5",
    "source": "TipRanks",
    "publish_date": "Thu, 23 Oct 2025 07:00:00 GMT"
  },
  {
    "title": "Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNSGRHNHlCV180NW9STVgteDBHeE53ZkhOMzIwOVdnR3BRQndid2hGTHo5QUJnS1NoLXd6S0hzYTN0V2hsaXNFakh3V25LelBpUEVHWkZUVUlGa2lfWXA0bHRIYUZUUWt4NWtwQzBtNmpocnVlMHFUNGRSdkpxbndoaHRUd3ViWG5JbW9B?oc=5\" target=\"_blank\">Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNSGRHNHlCV180NW9STVgteDBHeE53ZkhOMzIwOVdnR3BRQndid2hGTHo5QUJnS1NoLXd6S0hzYTN0V2hsaXNFakh3V25LelBpUEVHWkZUVUlGa2lfWXA0bHRIYUZUUWt4NWtwQzBtNmpocnVlMHFUNGRSdkpxbndoaHRUd3ViWG5JbW9B?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Thu, 25 Sep 2025 07:00:00 GMT"
  },
  {
    "title": "Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet - Yahoo Finance",
    "content": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxNWlR0eUE2RS1iejBxZld2NzM2TWM2R1hBend4OTNxTWUwczB6ZTZ4VXlnUFhhazFNNWR2SWhLZEhhVW8wWVVhUlVlZlpsTVpQZ01xa0ZjZHRYNHJxQ1B5YnUzQ244VmJ4cmRiZmZncFA3cWh0a0FmQUdxZkxDTW1DMFhsdWVyWlVFUjFyTUx4MV9DWFdZMGc?oc=5\" target=\"_blank\">Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNWlR0eUE2RS1iejBxZld2NzM2TWM2R1hBend4OTNxTWUwczB6ZTZ4VXlnUFhhazFNNWR2SWhLZEhhVW8wWVVhUlVlZlpsTVpQZ01xa0ZjZHRYNHJxQ1B5YnUzQ244VmJ4cmRiZmZncFA3cWh0a0FmQUdxZkxDTW1DMFhsdWVyWlVFUjFyTUx4MV9DWFdZMGc?oc=5",
    "source": "Yahoo Finance",
    "publish_date": "Thu, 25 Sep 2025 07:00:00 GMT"
  }
]